Pills

This is the text extract for Schedule Update - effective 1 March 2013, browse documents here.


Pharmaceutical Management Agency

Update

New Zealand Pharmaceutical Schedule

Effective 1 March 2013

Cumulative for January, February and March 2013 Section H cumulative for December 2012, January, February and March 2013


Contents

Summary of PHARMAC decisions effective 1 March 2013 ............................. 3 Ovestin vaginal cream ................................................................................... 5 Sildenafil funded for Raynaud’s Phenomenon ............................................... 5 Changes to chemical names and formulations .............................................. 5 Quinapril change of brand ............................................................................ 5 Omezol Relief 20 mg capsule contains tartrazine .......................................... 6 Brand Switch Fee on Caresens Meters extended............................................ 6 News in brief ................................................................................................. 6 Tender News .................................................................................................. 7 Looking Forward ........................................................................................... 7 Sole Subsidised Supply products cumulative to March 2013......................... 9 New Listings ................................................................................................ 20 Changes to Restrictions ............................................................................... 27 Changes to Subsidy and Manufacturer’s Price............................................. 32 Changes to General Rules............................................................................ 36 Changes to Brand Name ............................................................................. 37 Changes to PSO........................................................................................... 37 Changes to Section I ................................................................................... 38 Delisted Items ............................................................................................. 39 Items to be Delisted .................................................................................... 43 Section H changes to Part II ........................................................................ 46 Section H changes to Part III........................................................................ 54 Index ........................................................................................................... 55

2


Summary of PHARMAC decisions

EFFECTIVE 1 MARCH 2013 New listings (pages 20-26) • Sildenafil (Silagra) tab 25 mg and 50 mg – Retail pharmacy – Special Authority • Gentamicin sulphate (APP Pharmaceuticals) – inj 10 mg per ml, 2 ml – Subsidy by endorsement • Pramipexole hydrochloride (Dr Reddy’s Pramipexole) tab 1 mg • Oxycodone hydrochloride (OxyNorm) inj 50 mg per ml, 1 ml • Flutamide (Flutamin S29) tab 250 mg • Pharmacy Services (BSF Accarb, BSF Zetlam, BSF Alphapharm & BSF Entapone) brand switch fee Changes to restrictions (pages 27-31) • Acarbose (Accarb) – addition of brand switch fee payable • Blood glucose diagonostic test strip (Accu-Chek Performa and Freestyle Optium) – new Special Authority • Sildenafil – change to Special Authority criteria • Ethinyloestradiol with levonorgestrel (Ava 30 ED) – removal of brand switch fee payable • Ethambutol hydrochloride (Myambutol) – addition of S29 • Lamivudine (Zetlam) – addition of brand switch fee payable • Zidovudine [AZT] with lamivudine (Alphapharm) – addition of brand switch fee payable • Entacapone (Entapone) – addition of brand switch fee payable • Extension of BSF on Caresens N, Caresens N POP and Caresens II Decreased subsidy (pages 32-35) • Diclofenac sodium (Diclofenac Sandoz) tab EC 50 mg • Domperidone (Motilium) tab 10 mg • Doxorubicin (Baxter) inj 1 mg for ECP • Promethazine hydrochloride (Promethazine Winthrop Elixir) oral liq 5 mg per 5 ml Increased subsidy (pages 32-35) • Blood ketone diagnostic test meter (Freestyle Optium) meter • Ketone blood beta-ketone electrodes (Freestyle Optium Ketone) test strip • Blood glucose diagnostic test strip (Freestyle Optium and Accu-Chek Performa) blood glucose test strips • Danthron with poloxamer (Pinorax) oral liq 25 mg with poloxamer 200 mg per 5 ml • Danthron with poloxamer (Pinorax Forte) oral liq 75 mg with poloxamer 1 g per 5 ml

3


Summary of PHARMAC decisions – effective 1 March 2013 (continued) • Betamethasone valerate (Beta Cream) crm 0.1% • Betamethasone valerate (Beta Ointment) oint 0.1% • Clobetasol propionate (Dermol ) crm 0.05% and oint 0.05% • Betamethasone valerate (Beta Scalp) scalp app 0.1% • Trimethoprim (TMP) tab 300 mg • Baclofen (Pacifen) tab 10 mg • Tamoxifen citrate (Genox) tab 10 mg

4


Pharmaceutical Schedule - Update News

5

Ovestin vaginal cream

This is a reminder that Ovestin vaginal cream has no requirement to be discarded one month after opening. If the prescribed quantity equates to one tube per month then this will be subsidised. In all other circumstances only the quantity which equates to the dosing instructions will be subsidised. Providing good hygiene standards are met there is no requirement to discard the applicator after a calendar month’s use.

Sildenafil funded for Raynaud’s Phenomenon

From 1 March 2013 sildenafil will be available fully funded for Raynaud’s phenomenon, subject to Special Authority criteria. The Special Authority for Raynaud’s phenomenon can be applied for electronically while Special Authorities for pulmonary arterial hypertension will continue to be applied for via the PAH panel.

Changes to chemical names and formulations

Over the next few months there will be changes to some chemical names and formulations in the Pharmaceutical Schedule. This is to bring naming conventions in line with the proposed new Hospital Schedule (Preferred Medicines List).

Quinapril change of brand

Last month Arrow-Quinapril 5 mg, 10 mg and 20 mg tabs were listed fully funded in the Pharmaceutical Schedule. The Accupril brand of quinapril will be reference priced from 1 April 2013 and delisted from 1 July 2013. There will be a Brand Switch Fee payable on the Arrow brand of quinapril from 1 July to 1 October 2013.


6

Pharmaceutical Schedule - Update News

Omezol Relief 20 mg capsule contains tartrazine

Since October 2012 the Omezol Relief 20 mg brand of omeprazole has contained a small amount of tartrazine in the capsule shell. Although it is rare, some patients may be intolerant to tartrazine, and for these patients the Omezol Relief 20 mg capsule may be opened and the contents consumed or Omezol Relief 10 mg caps can be dispensed. Alternatively, patients may wish to discuss with their prescriber about alternative medications such as pantoprazole or lansoprazole. Please note that only the 20 mg strength of Omezol Relief contains tartrazine, and this is clearly indicated on the packaging.

Brand Switch Fee on Caresens Meters extended

The BSF on Caresens test strips has been extended to 30 June 2013. This coincides with extending the Pharmacist dispensing of and claiming for the meters without a prescription until 30 June 2013.

News in brief

• Dr Rod Ellis-Pegler is no longer practicing in New Zealand, therefore has been removed from the Register of Prescribers approved to apply for a Special Authority for antiretrovirals. • Pramipexole hydrochloride (Dr Reddy’s Pramipexole) tab 1 mg will be listed fully funded from 1 March 2013.


Tender News

Sole Subsidised Supply changes – effective 1 April 2013

Chemical Name Amitriptyline Dexamphetamine sulphate Hydrocortisone butyrate Hydrocortisone butyrate Hydrocortisone butyrate Isoniazid Isotretinoin Isotretinoin Lansoprazole Lansoprazole Megestrol acetate Nevirapine Pethidine hydrochloride Pethidine hydrochloride Phenobarbitone Phenobarbitone Pizotifen Presentation; Pack size Tab 10 mg; 100 tab Tab 5 mg; 100 tab Lipocream 0.1%; 30 g OP & 100 g OP Milky emul 0.1%; 100 ml OP Oint 0.1%; 100 g OP Tab 100 mg; 100 tab Cap 10 mg; 120 cap Cap 20 mg; 120 cap Cap 15 mg; 28 cap Cap 30 mg; 28 cap Tab 160 mg; 30 tab Tab 200 mg; 60 tab Tab 50 mg; 10 tab Tab 100 mg; 10 tab Tab 15 mg; 500 tab Tab 30 mg; 500 tab Tab 500 µg; 100 tab Sole Subsidised Supply brand (and supplier) Arrow-Amitriptyline (Arrow) PSM (API) Locoid Lipocream (CSL) Locoid Crelo (CSL) Locoid (CSL) PSM (API) Oratane (Douglas) Oratane (Douglas) Solox (Douglas) Solox (Douglas) Apo-Megestrol (Apotex) Nevirapine Alphapharm (Alphapharm) PSM (API) PSM (API) PSM (API) PSM (API) Sandomigran (Novartis)

Looking Forward

This section is designed to alert both pharmacists and prescribers to possible future changes to the Pharmaceutical Schedule. It may also assist pharmacists, distributors and wholesalers to manage stock levels. Possible decisions for future implementation 1 April 2013 • KetoCal 3:1 powder vanilla 300 g OP – Special Authority – Retail pharmacy new listing • Benzbromarone (Benzbromaron) tab 100 mg – Special Authority – Retail pharmacy – Section 29 – new listing • Diazoxide (Proglicem) cap 25 mg and 100 mg – Special Authority – Retail pharmacy – Section 29 – new listing • Para-amino salicylic acid (Paser) sachet 4 g – Retail pharmacy – Specialist – Section 29 – new listing • Paromomycin (Humatin) cap 250 mg – Special Authority – Retail pharmacy – Section 29 – new listing

7


Possible decisions for future implementation 1 April 2013 (continued) • Tetracycline (Tetracycline Wolff) cap 500 mg – Special Authority – Retail pharmacy – Section 29 – new listing • Bismuth trioxide (Bismuth) Cap 250 mg – Section 29 – new listing • Stiripentol (Diacomit) cap 250 mg and sachet 250 mg – Special Authority – Retail pharmacy – Section 29 – new listing • Pegaspargase (Oncaspar) inj 3,750 IU per 5 ml - PCT only- Specialist – Special Authority - Section 29 – new listing • Protionamide (Peteha) tab 250 mg – Special Authority – Retail pharmacySection 29 –new listing • Ciprofloxacin tab 250 mg, 500 mg and 750 mg – changes to restrictions • Clindamycin cap 150 mg and inj 150 mg – amendment to prescribing restriction • Colistin sulphomethate – amendment to prescribing restriction • Fusidic acid – amendment to prescribing restriction • Lincomycin – amendment to prescribing restriction • Itraconazole – amendment to prescribing restriction • Ketaconazole – amendment to prescribing restriction • Isoniazid – amendment to prescribing restriction • Pyrazinamide – amendment to prescribing restriction • Rifabutin – amendment to prescribing restriction • Rifampicin – amendment to prescribing restriction • Albendazole (GSK) tab 200 mg – Special Authority – Retail pharmacy – new listing • Primaquine phosphate (Primacin) tab 7.5 mg– Special Authority – Retail pharmacy – new listing • Pyrimethamine (Daraprim) tab 25 mg – Special Authority – Retail pharmacy – new listing • Efavirenz (Stocrin) oral liq 30 mg per ml – Special Authority – Retail pharmacy – new listing • Clofazamine (Lamprene) cap 50 mg – Special Authority – Retail pharmacy – new listing • Cycloserine (King) cap 250 mg – Special Authority – Retail pharmacy – new listing • Itraconazole (Sporanox) oral liq 10 mg per ml – Special Authority – Retail pharmacy – new listing • Sulfadiazine sodium (Wockhardt) tab 500 mg – Special Authority – Retail pharmacy – new listing

8


Sole Subsidised Supply Products – cumulative to March 2013

Generic Name

Abacavir sulphate Acarbose Acetazolamide Acetylcysteine Aciclovir Allopurinol Amantadine hydrochloride Aminophylline Amitriptyline Amlodipine Amoxycillin Amoxycillin clavulanate

Presentation

Oral liq 20 mg per ml Tab 300 mg Tab 50 mg and 100 mg Tab 250 mg Inj 200 mg per ml, 10 ml Tab dispersible 200 mg, 400 mg & 800 mg Tab 100 mg & 300 mg Cap 100 mg Inj 25 mg per ml, 10 ml Tab 25 mg & 50 mg Tab 2.5 mg Tab 5 mg & 10 mg Inj 250 mg, 500 mg & 1 g Cap 250 mg & 500 mg Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml Tab 500 mg with potassium clavulanate 125 mg Crm Tab 100 mg Tab 100 mg Tab dispersible 300 mg Tab 50 mg & 100 mg Tab 10 mg, 20 mg, 40 mg & 80 mg Inj 600 µg, 1 ml Tab 50 mg Inj 50 mg Tab 2.5 mg & 5 mg Inj 1.2 mega u per 2.3 ml Inj 600 mg Eye drops 0.5% Eye drops 0.25% Tab long-acting 400 mg

Brand Name Expiry Date*

Ziagen Ziagen Accarb Diamox Martindale Acetylcysteine Lovir Apo-Allopurinol Symmetrel DBL Aminophylline Amitrip Apo-Amlodipine Apo-Amlodipine Ibiamox Alphamox Augmentin Augmentin Curam Duo AFT Vitala-C Ethics Aspirin EC Ethics Aspirin Mylan Atenolol Zarator AstraZeneca Imuprine Imuran ArrowBendrofluazide Bicillin LA Sandoz Betoptic Betoptic S Bezalip Retard 2014 2014 2013 2013 2015 2015 2015 2013 2014 2015 2014 2014 2015 2014 2015 2014 2015 2013 2014 2014 2014 2014 2014 2014 2013 2015

Aqueous cream Ascorbic acid Aspirin Atenolol Atorvastatin Atropine sulphate Azathioprine Bendrofluazide Benzathine benzylpenicillin Benzylpenicillin sodium (Penicillin G) Betaxolol hydrochloride Bezafibrate

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

9


Sole Subsidised Supply Products – cumulative to March 2013

Generic Name

Bicalutamide Bisacodyl Bisoprolol fumarate Blood glucose diagnostic test meter Blood glucose diagnostic test strip Brimonidine tartrate Cabergoline Calamine Calcitonin Calcium carbonate Calcium folinate Candesartan Captopril Cefaclor monohydrate Cefazolin sodium Ceftriaxone sodium Cefuroxime sodium Cetomacrogol Cetirizine hydrochloride Chloramphenicol Chlorhexidine gluconate

Presentation

Tab 50 mg Tab 5 mg Tab 2.5 mg, 5 mg & 10 mg Meter with 50 lancets, a lancing device and 10 diagnostic test strips Blood glucose test strips Eye drops 0.2% Tab 0.5 mg Lotn, BP Inj 100 iu per ml, 1 ml Tab 1.25 g (500 mg elemental) Tab eff 1.75 g (1 g elemental) Tab 15 mg Tab 4 mg, 8 mg, 16 mg & 32 mg Tab 12.5 mg, 25 mg & 50 mg Oral liq 5 mg per ml Grans for oral liq 125 mg per 5 ml Inj 500 mg & 1 g Inj 500 mg Inj 1 g Inj 750 mg Crm BP Oral liq 1 mg per ml Tab 10 mg Eye oint 1% Eye drops 0.5% Mouthwash 0.2% Handrub 1% with ethanol 70% Soln 4% Nail-soln 8% Tab 0.5 mg, 2.5 mg & 5 mg Tab 5 mg with hydrochlorothiazide 12.5 mg Tab 250 mg, 500 mg & 750 mg Tab 20 mg Tab 500 mg Tab 250 mg

Brand Name Expiry Date*

Bicalaccord Lax-Tab Bosvate CareSens N CareSens N POP CareSens II CareSens CareSens N Arrow-Brimonidine Dostinex PSM Miacalcic Arrow-Calcium Calsource DBL Leucovorin Calcium Candestar m-Captopril Capoten Ranbaxy-Cefaclor AFT Veracol Aspen Ceftriaxone Multichem PSM Cetirizine - AFT Zetop Chlorsig Chlorafast healthE healthE Orion Apo-Ciclopirox Zapril Inhibace Plus Cipflox Arrow-Citalopram Apo-Clarithromycin Apo-Clarithromycin 2014 2013 2013 2015

2015 2014 2015 2015 2014 2014 2014 2015 2013 2013 2014 2013 2014 2013 2014 2015 2015 2014 2015 2013 2013 2014 2014 2014

Ciclopirox olamine Cilazapril Cilazapril with hydrochlorothiazide Ciprofloxacin Citalopram hydrobromide Clarithromycin

10

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.


Sole Subsidised Supply Products – cumulative to March 2013

Generic Name

Clindamycin Clomipramine hydrochloride Clonidine hydrochloride Clopidogrel Clotrimazole

Presentation

Cap hydrochloride 150 mg Tab 10 mg & 25 mg Tab 150 µg Inj 150 µg per ml, 1 ml Tab 75 mg Crm 1% Vaginal crm 1% with applicator Vaginal crm 2% with applicator Soln BP Tab 500 µg Powder for soln for oral use 4.4 g Crm 10% Tab 50 mg Tab 50 mg Oral liq 100 mg per ml Tab 50 mg & 100 mg Tab 2 mg with ethinyloestradiol 35 µg and 7 inert tabs Nasal spray 10 µg per dose Tab 1 mg & 4 mg Eye oint 0.1% Eye drops 0.1% Inj 4 mg per ml, 1 ml & 2 ml

Brand Name Expiry Date*

Clindamycin ABM Apo-Clomipramine Catapres Apo-Clopidogrel Clomazol Clomazol Clomazol Midwest Colgout Electral Itch-Soothe Nausicalm Cycloblastin Neoral Siterone Ginet 84 Desmopressin-PH&T Douglas Maxidex Maxidex Hospira Maxitrol Maxitrol 2013 2015 2015 2013 2014 2013 2013 2013 2013 2015 2015 2013 2015 2015 2014 2014 2015 2014 2013 2013 2014

Coal tar Colchicine Compound electrolytes Crotamiton Cyclizine hydrochloride Cyclophosphamide Cyclosporin Cyproterone acetate Cyproterone acetate with ethinyloestradiol Desmopressin Dexamethasone

Dexamethasone sodium phosphate

Dexamethasone with neomycin Eye oint 0.1% with neomycin sulphate and polymyxin b sulphate 0.35% and polymyxin B sulphate 6,000 u per g Eye drops 0.1% with neomycin sulphate 0.35% and polymyxin B sulphate 6,000 u per ml Dextrose Dextrose with electrolytes Inj 50%, 10 ml Soln with electrolytes

Biomed Pedialyte – Fruit Pedialyte – Bubblegum Pedialyte – Plain Diclax SR Voltaren Voltaren Ophtha Voltaren DHC Continus Dilzem

2014 2013

Diclofenac sodium

Tab long-acting 75 mg & 100 mg Inj 25 mg per ml, 3 ml Eye drops 1 mg per ml Suppos 12.5 mg, 25 mg, 50 mg & 100 mg Tab long-acting 60 mg Tab 30 mg & 60 mg

2015 2014

Dihydrocodeine tartrate Diltiazem hydrochloride

2013 2015

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

11


Sole Subsidised Supply Products – cumulative to March 2013

Generic Name

Dipyridamole Docusate sodium Docusate sodium with sennosides Doxazosin mesylate Doxycycline hydrochloride Emulsifying ointment Enalapril Enoxaparin sodium Entacapone Ergometrine maleate Escitalopram Etidronate disodium Ethinyloestradiol Ethinyloestradiol with levonorgestrel

Presentation

Tab long-acting 150 mg Cap 50 mg Cap 120 mg Tab 50 mg with total sennosides 8 mg Tab 2 mg & 4 mg Tab 100 mg Oint BP Tab 5 mg, 10 mg & 20 mg Inj 20 mg, 40 mg, 60 mg, 80 mg, 100 mg, 120 mg & 150 mg Tab 200 mg Inj 500 µg per ml, 1 ml Tab 10 mg & 20 mg Tab 200 mg Tab 10 µg Tab 20 µg with levonorgestrel 100 µg & 7 inert tab Tab 30 µg with levonorgestrel 150 µg & 7 inert tab Tab 25 mg Tab long-acting 5 mg & 10 mg Tab long-acting 2.5 mg Transdermal patch 12.5 µg per hour, 25 µg per hour, 50 µg per hour, 75 µg per hour, 100 µg per hour Inj 50 µg per ml, 2 ml & 10 ml Oral liq 30 mg per 1 ml (6 mg elemental per 1 ml) Inj 300 µg per 0.5 ml Inj 480 µg per 0.5 ml Tab 5 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Cap 250 mg & 500 mg Inj 250 mg, 500 mg & 1 g Cap 50 mg, 150 mg & 200 mg Eye drops 0.1% Crm 5%

Brand Name Expiry Date*

Pytazen SR Laxofast 50 Laxofast 120 Laxsol Apo-Doxazosin Doxine AFT m-Enalapril Clexane Entapone DBL Ergometrine Loxalate Arrow-Etidronate NZ Medical and Scientific Ava 20 ED Ava 30 ED Aromasin Plendil ER Plendil ER Mylan Fentanyl Patch Boucher and Muir Ferodan Zarzio Zarzio Rex Medical AFT Staphlex Flucloxin Ozole Flucon Efudix 2014 2015 2013 2014 2014 2013 2014 2014 2014 2015 2015 2015 2014 2013 2015 2015 2014

Exemestane Felodopine Fentanyl

Fentanyl citrate Ferrous sulphate Filgrastim Finasteride Flucloxacillin sodium

2015 2013

31/12/15

2014 2015 2014 2014 2015 2015

Fluconazole Fluorometholone Fluorouracil sodium

12

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.


Sole Subsidised Supply Products – cumulative to March 2013

Generic Name

Fluoxetine hydrochloride Flutamide Fluticafone propionate Furosemide

Presentation

Cap 20 mg Tab dispersible 20 mg, scored Tab 250 mg Metered aqueous nasal spray, 50 µg per dose Tab 500 mg Tab 40 mg Inj 10 mg per ml, 2 ml Crm 2% Oint 2% Tab 600 mg Inj 40 mg per ml, 2 ml Tab 80 mg Tab 5 mg Suppos 3.6 g Liquid Aerosol spray 400 µg per dose TDDS 5 mg & 10 mg Tab 600 µg Inj 5 mg per ml, 1 ml Oral liq 2 mg per ml Tab 500 µg, 1.5 mg & 5 mg Tab 5 mg & 20 mg Crm 1% Powder Inj 50 mg per ml, 1 ml Rectal foam 10%, CFC-Free (14 applications) Crm 1% with miconazole nitrate 2% Lotn 1% with wool fat hydrous 3% and mineral oil Inj 1 mg per ml, 1 ml Tab 200 mg Inj 20 mg, 1 ml Tab 10 mg Tab 200 mg Tab long-acting 800 mg Oral liq 100 mg per 5 ml Crm 5% Tab 2.5 mg

Brand Name Expiry Date*

Fluox Fluox Flutamin Flixonase Hayfever & Allergy Urex Forte Diurin 40 Frusemide-Claris Foban Foban Lipazil Pfizer Apo-Gliclazide Minidiab PSM healthE Glytrin Nitroderm TTS Lycinate Serenace Serenace Serenace Douglas Pharmacy Health ABM Solu-Cortef Colifoam Micreme H DP Lotn HC ABM Hydroxocobalamin Plaquenil Buscopan Gastrosoothe Arrowcare Brufen SR Fenpaed Aldara Dapa-Tabs 2013 2013 2015 2015 2013 2013 2013 2015 2014 2015 2015 2013 2014

Fusidic acid Gemfibrozil Gentamicin sulphate Gliclazide Glipizide Glycerol Glyceryl trinitrate

Haloperidol

2013

Hydrocortisone

2015 2014 2013 2015 2013 2014 2015 2015 2014 2014 2013 2014 2013

Hydrocortisone acetate Hydrocortisone with miconazole Hydrocortisone with wool fat and mineral oil Hydroxocobalamin Hydroxychloroquine sulphate Hyoscine N-butylbromide Ibuprofen

Imiquimod Indapamide

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

13


Sole Subsidised Supply Products – cumulative to March 2013

Generic Name

Ipratropium bromide

Presentation

Aqueous nasal spray, 0.03%, 15 ml OP Nebuliser soln, 250 µg per ml, 1 ml & 2 ml Inj 50 mg per ml, 2 ml Tab 20 mg Tab long-acting 40 mg Cap 100 mg Shampoo 2% Oral liq 10 g per 15 ml Tab 100 mg Oral liq 10 mg per ml Tab 150 mg Eye drops 50 µg per ml Tab 2.5 mg Subdermal implant (2 x 75 mg rods) Viscous soln 2% Inj 1%, 5 ml & 20 ml Crm 2.5% with prilocaine 2.5% (5 g tubes) Crm 2.5% with prilocaine 2.5%; 30 g OP Tab 5 mg, 10 mg & 20 mg Tab 250 mg & 400 mg Cap 250 mg Eye drops 0.1% Cap 2 mg Oral liq 1 mg per ml Tab 10 mg Tab 1 mg & 2.5 mg Tab 12.5 mg, 25 mg, 50 mg & 100 mg Tab 50 mg with hydrochlorothiazide 12.5 mg Powder 13.125 g, sachets Liq 0.5% Shampoo 1% Size 2 Tab 100 mg

Brand Name Expiry Date*

Univent Univent Ferrum H Ismo 20 Corangin Itrazole Sebizole Laevolac Zetlam 3TC 3TC Hysite Letraccord Jadelle Xylocaine Viscous Xylocaine EMLA EMLA Arrow-Lisinopril Lithicarb FC Douglas Lomide Diamide Relief Lorapaed Loraclear Hayfever Relief Ativan Lostaar Arrow-Losartan & Hydroclorothiazide Lax-Sachets A-Lices A-Lices EZ-fit Paediatric Mask De-Worm 2015 2015 2014 2014 2013 2013 2014 2014 2013 2014 2013 2014 2013 2015 2015 31/12/13 2014 2013 2013 2013

Iron polymaltose Isosorbide mononitrate Itraconazole Ketoconazole Lactulose Lamivudine

Latanoprost Letrozole Levonorgestrel Lignocaine hydrochloride Lignocaine with prilocaine

Lisinopril Lithium carbonate Lodoxamide trometamol Loperamide hydrochloride Loratadine

Lorazepam Losartan Losartan with hydrochlorothiazide Macrogol 3350 Malathion Mask for spacer device Mebendazole

2013 2014 2014 2014 2013 2015 2014

14

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.


Sole Subsidised Supply Products – cumulative to March 2013

Generic Name

Mebeverine hydrochloride Methylprednisolone Methylprednisolone acetate Methylprednisolone acetate with lignocaine Mercaptopurine Mesalazine Metformin hydrochloride Methadone hydrochloride

Presentation

Tab 135 mg Tab 4 mg & 100 mg Inj 40 mg per ml Inj 40 mg per ml with lignocaine 1 ml Tab 50 mg Enema 1 g per 100 ml Suppos 500 mg Tab immediate-release 500 mg & 850 mg Oral liq 2 mg per ml Oral liq 5 mg per ml Oral liq 10 mg per ml Tab 5 mg Inj 25 mg per ml, 2 ml & 20 ml Inj 40 mg per ml, 1 ml; 62.5 mg per ml, 2 ml; 500 mg & 1 g Inj 5 mg per ml, 2 ml Tab 10 mg Tab long-acting 23.75 mg, 47.5 mg, 95 mg & 190 mg Inj 1 mg per ml, 5 ml Tab 50 mg & 100 mg Tab long-acting 200 mg Crm 2% Tab 30 mg & 45 mg Crm 0.1% Oint 0.1% Oral liq 1 mg per ml, 2 mg per ml, 5 mg per ml & 10 mg per ml Inj 5 mg per ml, 1 ml Inj 10 mg per ml, 1 ml Inj 15 mg per ml, 1 ml Inj 30 mg per ml, 1 ml Tab long-acting 10 mg, 30 mg, 60 mg & 100 mg Cap long-acting 10 mg, 30 mg, 60 mg & 100 mg

Brand Name Expiry Date*

Colofac Medrol Depo-Medrol Depo-Medrol with Lidocaine Purinethol Pentasa Asacol Apotex Biodone Biodone Forte Biodone Extra Forte Methatabs Hospira Solu-Medrol Pfizer Metamide Metoprolol-AFT CR Lopresor Lopresor Slow-Lopresor Multichem Avanza m-Mometasone RA-Morph DBL Morphine Sulphate DBL Morphine Sulphate DBL Morphine Sulphate DBL Morphine Sulphate Arrow-Morphine LA m-Elson Hospira Konsyl-D 2013 2013 2014 2015 2015 2015 2013 2015 2014 2015 2015 2013 2013 2015 2014 2015 2015

Methotrexate Methylprednisolone sodium succinate Metoclopramide hydrochloride Metoprolol succinate Metoprolol tartrate

Miconazole nitrate Mirtazapine Mometasone furoate Morphine hydrochloride Morphine sulphate

2014 2015 2015 2015 2014

2013

Morphine tartrate Mucilaginous laxatives

Inj 80 mg per ml, 1.5 ml & 5 ml Dry

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

15


Sole Subsidised Supply Products – cumulative to March 2013

Generic Name

Naphazoline hydrochloride Naproxen Naltrexone hydrochloride Neostigmine Nicotine

Presentation

Eye drops 0.1% Tab 250 mg Tab 500 mg Tab 50 mg Inj 2.5 mg per ml, 1 ml Gum 2 mg & 4 mg (classic, fruit, mint) Lozenge 1 mg & 2 mg Patch 7 mg, 14 mg & 21 mg Tab 50 mg & 500 mg Tab 400 mg Tab 350 µg Tab 5 mg Oral liq 100,000 u per ml Cap 500,000 u Tab 500,000 u Inj 50 µg per ml, 1 ml Inj 100 µg per ml, 1 ml Inj 500 µg per ml, 1 ml Crm Cap 10 mg, 20 mg & 40 mg Powder Inj 40 mg Tab disp 8 mg Tab 4 mg & 8 mg

Brand Name Expiry Date*

Naphcon Forte Noflam 250 Noflam 500 Naltraccord AstraZeneca Habitrol Habitrol Habitrol Apo-Nicotinic Acid Arrow-Norfloxacin Noriday 28 Primolut N Nilstat Nilstat Nilstat Octreotide Max Rx 2014 2014 2015 2014 2014 2013 2014 2014 2015 2013 2014 2014

Nicotinic acid Norfloxacin Norethisterone Nystatin

Octreotide (somatostatin analogue) Oil in water emulsion Omeprazole

healthE Fatty Cream Omezol Relief Midwest Dr Reddy’s Omeprazole Dr Reddy’s Ondansetron Dr Reddy’s Ondansetron Ox-Pam Oxycodone Orion Syntometrine Pantocid IV Dr Reddy’s Pantoprazole Paracare Parafast Ethics Paracetamol Paracare Double Strength Paracetamol + Codeine (Relieve) Lacri-Lube

2015 2014

Ondansetron

2013

Oxazepam Oxycodone hydrochloride Oxytocin Pantoprazole

Tab 10 mg & 15 mg Inj 10 mg per ml, 1 ml & 2 ml Inj 5 iu with ergometrine maleate 500 µg per ml, 1 ml Inj 40 mg Tab 20 mg & 40 mg Suppos 500 mg Tab 500 mg Oral liq 120 mg per 5 ml Oral liq 250 mg per 5 ml Tab paracetamol 500 mg with codeine phosphate 8 mg Eye oint with soft white paraffin

2014 2015 2015 2014 2013 2015 2014

Paracetamol

Paracetamol with codeine Paraffin liquid with soft white paraffin

2014 2013

16

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.


Sole Subsidised Supply Products – cumulative to March 2013

Generic Name

Paroxetine hydrochloride Peak flow meter Pergolide Permethrin Pethidine hydrochloride

Presentation

Tab 20 mg Low range & normal range Tab 0.25 mg & 1 mg Crm 5% Lotn 5% Inj 50 mg per ml, 1 ml Inj 50 mg per ml, 2 ml

Brand Name Expiry Date*

Loxamine Breath-Alert Permax Lyderm A-Scabies DBL Pethidine Hydrochloride DBL Pethidine Hydrochloride Cilicaine VK AFT AFT Pizaccord Coloxyl Span-K Dr Reddy’s Pramipexole Cholvastin Cilicaine Allersoothe Mestinon PyridoxADE Apo-Pyridoxine Accuretic 10 Accuretic 20 Peptisoothe Arrow-Ranitidine Mycobutin Norvir Rizamelt Ropin ArrowRoxithromycin Asthalin Duolin 2014 2013 2015 2014 2013 2015 2015 2015 2015 2014 2015 2013 2014 2014 2015 2014 2014 2015 2013 2015 2014 2014 2014

Phenoxymethylpenicillin (Pencillin V)

Cap potassium salt 250 mg & 500 mg Grans for oral liq 125 mg per 5 ml Grans for oral liq 250 mg per 5 ml Tab 15 mg, 30 mg & 45 mg Oral drops 10% Tab long-acting 600 mg Tab 0.125 mg & 0.25 mg Tab 20 mg & 40 mg Inj 1.5 mega u Tab 10 mg & 25 mg Tab 60 mg Tab 25 mg Tab 50 mg Tab 10 mg with hydrochlorothiazide 12.5 mg Tab 20 mg with hydrochlorothiazide 12.5 mg Oral liq 150 mg per 10 ml Tab 150 mg & 300 mg Cap 150 mg Tab 100 mg Tab orodispersible 10 mg Tab 0.25 mg, 1 mg, 2 mg & 5 mg Tab 150 mg & 300 mg Nebuliser soln, 1 mg per ml & 2 mg per ml, 2.5 ml Nebuliser soln, 2.5 mg with ipratropium bromide 0.5 mg per vial, 2.5 ml

2013

Pioglitazone Poloxamer Potassium chloride Pramipexole hydrochloride Pravastatin Procaine penicillin Promethazine hydrochloride Pyridostigmine bromide Pyridoxine hydrochloride Quinapril with hydrochlorothiazide

Ranitidine hydrochloride Rifabutin Ritonavir Rizatriptan Ropinirole hydrochloride Roxithromycin Salbutamol Salbutamol with ipratropium bromide

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

17


Sole Subsidised Supply Products – cumulative to March 2013

Generic Name

Sertraline Simvastatin

Presentation

Tab 50 mg & 100 mg Tab 10 mg Tab 20 mg Tab 40 mg Tab 80 mg Inj 23.4%, 20 ml Enema 90 mg with sodium lauryl sulphoacetate 9 mg per ml, 5 ml Grans effervescent 4 g sachets Eye drops 2% 800 ml 230 ml (single patient) Tab 25 mg & 100 mg Inj 12 mg per ml, 0.5 ml Tab 50 mg & 100 mg Tab 20 mg Cap 400 µg Soln 2.3% with triethanolamine lauryl sulphate and fluorescein sodium, 500 ml & 1,000 ml Tab 10 mg Cap 5 mg, 20 mg, 100 mg & 250 mg Tab 1 mg, 2 mg & 5 mg Tab 250 mg Inj long-acting 100 mg per ml, 10 ml Cap 40 mg Tab 25 mg Inj 250 µg Inj 1 mg per ml, 1 ml Eye drops 0.25% & 0.5% Eye drops 0.3% Eye oint 0.3% Inj 40 mg per ml, 2 ml Tab 100 mg Cap 50 mg

Brand Name Expiry Date*

Arrow-Sertraline Arrow-Simva 10mg Arrow-Simva 20mg Arrow-Simva 40mg Arrow-Simva 80mg Biomed Micolette Ural Rexacrom Volumatic Space Chamber Plus Spirotone Arrow-Sumatriptan Arrow-Sumatriptan Genox Tamsulosin-Rex Pinetarsol 2013 2014

Sodium chloride Sodium citrate with sodium lauryl sulphoacetate Sodium citro-tartrate Sodium cromoglycate Spacer device

2013 2013 2013 2013 2015

Spironolactone Sumatriptan Tamoxifen citrate Tamsulosin hydrochloride Tar with triethanolamine lauryl sulphate and fluorescein Temazepam Temozolomide Terazosin hydrochloride Terbinafine Testosterone cypionate Testosterone undecanoate Tetrabenazine Tetracosactrin Timolol maleate Tobramycin

2013 2013 2014 2013 2014

Normison Temaccord Arrow Dr Reddy’s Terbinafine Depo-Testosterone Andriol Testocaps Motetis Synacthen Synacthen Depot Arrow-Timolol Tobrex Tobrex DBL Tobramycin Tasmar Arrow-Tramadol

2014 2013 2013 2014 2014 2015 2013 2014 2014 2014

Tolcapone Tramadol hydrochloride

2014 2014

18

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.


Sole Subsidised Supply Products – cumulative to March 2013

Generic Name

Triamcinolone acetonide

Presentation

Inj 10 mg per ml, 1 ml Inj 40 mg per ml, 1 ml Crm 0.02% Oint 0.02% 0.1% in Dental Paste USP Tab 500 mg Eye drops 0.5% & 1% Eye drops 0.25% Cap 250 mg Inj 500 mg Tab 40 mg & 80 mg Tab, strong, BPC Tab (BPC cap strength) Cap 100 mg Oral liq 10 mg per ml Tab 300 mg with lamivudine 150 mg Oint BP Caps 137.4 mg (50 mg elemental)

Brand Name Expiry Date*

Kenacort-A Kenacort-A40 Aristocort Aristocort Oracort Cyklokapron Mydriacyl Enuclene Ursosan Mylan Isoptin B-PlexADE MultiADE Retrovir Retrovir Alphapharm Multichem Zincaps 2014

Tranexamic acid Tropicamide Tyloxapol Ursodeoxycholic acid Vancomycin hydrochloride Verapamil hydrochloride Vitamin B complex Vitamins Zidovudine [AZT] Zidovudine [AZT] with lamivudine Zinc and castor oil Zinc sulphate March changes in bold

2013 2014 2014 2014 2014 2014 2013 2013 2013 2014 2014 2014

*Expiry date of the Sole Subsidised Supply period is 30 June of the year indicated unless otherwise stated. Please note that Sole Subsidised Supply may have been awarded for a wider scope than just those presentation(s) listed in the above table.

19


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings

Effective 1 March 2013

58 SILDENAFIL – Special Authority see SA1293 – Retail pharmacy Tab 25 mg ................................................................................ 1.85 Tab 50 mg ................................................................................ 1.85 GENTAMICIN SULPHATE Inj 10 mg per ml, 2 ml – Subsidy by endorsement ................. 175.10 4 4 25 ✔ Silagra ✔ Silagra ✔ APP Pharmaceuticals

S29

88

Only if prescribed for a dialysis or cystic fibrosis patient or for prophylaxis of endocarditis and the prescription is endorsed accordingly. 119 123 PRAMIPEXOLE HYDROCHLORIDE s Tab 1 mg .................................................................................. 7.20 OXYCODONE HYDROCHLORIDE a) Only on a controlled drug form b) See prescribing guideline below c) No patient co-payment payable d) Safety medicine; prescriber may determine dispensing frequency Inj 50 mg per ml, 1 ml ............................................................. 60.00 FLUTAMIDE – Retail pharmacy-Specialist Tab 250 mg ............................................................................ 16.50 PHARMACY SERVICES - May only be claimed once per patient ❋ Brand switch fee........................................................................ 4.33 The Pharmacode for BSF Zetlam is 2433257 (BSF Zetlam Brand switch fee to be delisted 1 June 2013) ❋ Brand switch fee........................................................................ 4.33 The Pharmacode for BSF Alphapharm is 2433494 (BSF Alphapharm Brand switch fee to be delisted 1 June 2013) ❋ Brand switch fee........................................................................ 4.33 The Pharmacode for BSF Entapone is 2433249 (BSF Entapone Brand switch fee to be delisted 1 June 2013) ❋ Brand switch fee........................................................................ 4.33 The Pharmacode for BSF Accarb is 2433486 (BSF Accarb Brand switch fee to be delisted 1 June 2013) 30 ✔ Dr Reddy’s Pramipexole

5 30 1 fee 1 fee 1 fee 1 fee

✔ OxyNorm ✔ Flutamin S29 S29 ✔ BSF Zetlam ✔ BSF Alphapharm ✔ BSF Entapone ✔ BSF Accarb

158 177

Effective 1 February 2013

51 53 QUINAPRIL ❋ Tab 5 mg ................................................................................. 3.44 ❋ Tab 10 mg ............................................................................... 4.64 ❋ Tab 20 mg ................................................................................ 6.34 ATENOLOL ❋ Oral liq 25 mg per 5 ml ............................................................ 21.25 Restricted to children under 12 years of age. 90 90 90 ✔ Arrow-Quinapril 5 ✔ Arrow-Quinapril 10 ✔ Arrow-Quinapril 20

300 ml OP ✔ Atenolol AFT S29

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

20

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings - effective 1 February 2013 (continued)

86 FLUCLOXACILLIN SODIUM Grans for oral liq 125 mg per 5 ml – Up to 200 ml available on a PSO ............................................................................... 2.49 Grans for oral liq 250 mg per 5 ml – Up to 200 ml available on a PSO ............................................................................... 3.25 Note – this listing is for a sugar free formulation with new pharmacodes. CAPSAICIN – Special Authority see SA1289 – Retail pharmacy Crm 0.025% .............................................................................. 9.95

100 ml 100 ml

✔ AFT ✔ AFT

102

45 g OP

✔ Zostrix

➽ SA1289 Special Authority for Subsidy Initial application from any relevant practitioner. Approvals valid without further renewal unless notified where the patient has osteoarthritis that is not responsive to paracetamol and oral non-steroidal anti-inflammatories are contraindicated. 126 VENLAFAXINE – Special Authority see SA1061 – Retail pharmacy Tab 225 mg ........................................................................... 35.12 AZATHIOPRINE – Retail pharmacy-Specialist ❋ Tab 50 mg – For azathioprine oral liquid formulation refer, page 179 ............................................................................. 18.45 FLUTICASONE PROPIONATE Metered aqueous nasal spray, 50 µg per dose ........................... 2.30 28 ✔ Arrow-Venlafaxine XR

160 171

100

✔ Imuran

120 dose OP ✔ Flixonase Hayfever & Allergy Note – this Flixonase Hayfever & Allergy has different packaging and a new pharmacode 191 ENTERAL/ORAL FEED 1KCAL/ML – Special Authority see SA1098 – Hospital pharmacy [HP3] Powder (unflavoured) .............................................................. 78.97 400 g OP ✔ Heparon Junior

New Listings - effective 1 January 2013

32 INSULIN PUMP – Special Authority see SA1237– Retail pharmacy a) Only on a prescription b) Maximum of 1 insulin pump per prescription c) Maximum of 1 insulin pump per patient each four year period Min basal rate 0.05 U/h; clear colour .................................. 4,400.00 Min basal rate 0.05 U/h; smoke colour................................ 4,400.00 Min basal rate 0.05 U/h; purple colour ................................ 4,400.00 Min basal rate 0.05 U/h; pink colour ................................... 4,400.00 Min basal rate 0.05 U/h; blue colour ................................... 4,400.00

1 1 1 1 1

✔ Paradigm 522 ✔ Paradigm 722 ✔ Paradigm 522 ✔ Paradigm 722 ✔ Paradigm 522 ✔ Paradigm 722 ✔ Paradigm 522 ✔ Paradigm 722 ✔ Paradigm 522 ✔ Paradigm 722

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

21


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings - effective 1 January 2013 (continued)

35 INSULIN PUMP RESERVOIR – Special Authority see SA1240 – Retail pharmacy a) Maximum of 3 packs per prescription, b) Maximum of 1 prescription per 90 days. c) Only on a prescription Note: One additional pack of reservoirs will be funded per year (Maximum of 13 packs per annum) Cartridge for 5 and 7 series pump; 1.8 ml x 10 ........................ 50.00 1 OP ✔ Paradigm 1.8 Reservoir Cartridge for 7 series pump; 3.0 ml x 10 .................................. 50.00 1 OP ✔ Paradigm 3.0 Reservoir Syringe and cartridge for 50X pump, 3.0 ml x 10...................... 50.00 1 OP ✔ 50X 3.0 Reservoir INSULIN PUMP INFUSION SET (TEFLON CANNULA, ANGLE INSERTION) – Special Authority see SA1240 – Retail pharmacy a) Maximum of 3 packs per prescription, b) Maximum of 1 prescription per 90 days. c) Only on a prescription Note: One additional pack of infusion sets will be funded per year (Maximum of 13 packs per annum) 13 mm teflon cannula; angle insertion; 45 cm line x 10 with 10 needles;........................................ 130.00 1 OP ✔ Paradigm Silhouette MMT-368 13 mm teflon cannula; angle insertion; 60 cm line x 10 with 10 needles;........................................ 130.00 1 OP ✔ Paradigm Silhouette MMT-381 13 mm teflon cannula; angle insertion; 80 cm line x 10 with 10 needles;........................................ 130.00 1 OP ✔ Paradigm Silhouette MMT-383 13 mm teflon cannula; angle insertion; 120 cm line x 10 with 10 needles;...................................... 130.00 1 OP ✔ Paradigm Silhouette MMT-382 17 mm teflon cannula; angle insertion; 110 cm line x 10 with 10 needles; luer lock ........................ 130.00 1 OP ✔ Silhouette MMT-371 17 mm teflon cannula; angle insertion; 60 cm line x 10 with 10 needles; luer lock .......................... 130.00 1 OP ✔ Silhouette MMT-373 17 mm teflon cannula; angle insertion; 110 cm line x 10 with 10 needles;...................................... 130.00 1 OP ✔ Paradigm Silhouette MMT-377 17 mm teflon cannula; angle insertion; 60 cm line x 10 with 10 needles;........................................ 130.00 1 OP ✔ Paradigm Silhouette MMT-378 17 mm teflon cannula; angle insertion; 80 cm line x 10 with 10 needles;........................................ 130.00 1 OP ✔ Paradigm Silhouette MMT-384

34

34

INSULIN PUMP INFUSION SET (TEFLON CANNULA, STRAIGHT INSERTION) – Special Authority see SA1240 – Retail pharmacy a) Maximum of 3 packs per prescription, b) Maximum of 1 prescription per 90 days. c) Only on a prescription Note: One additional pack of infusion sets will be funded per year (Maximum of 13 packs per annum) 9 mm teflon cannula; straight insertion; 80 cm tubing x 10 with 10 needles; ................................... 130.00 1 OP ✔ Paradigm Quick-Set MMT-386 continued... Patients pay a manufacturer’s surcharge when S29 Unapproved medicine supplied under Section 29 the Manufacturer’s Price is greater than the Subsidy ‡ safety cap reimbursed Sole Subsidised Supply

22


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings - effective 1 January 2013 (continued)

continued... 6 mm teflon cannula; straight insertion; 80 cm tubing x 10 with 10 needles; ................................... 130.00 9 mm teflon cannula; straight insertion; 110 cm tubing x 10 with 10 needles; luer lock.................... 130.00 6 mm teflon cannula; straight insertion; 110 cm tubing x 10 with 10 needles; luer lock.................... 130.00 9 mm teflon cannula; straight insertion; 60 cm tubing x 10 with 10 needles; luer lock...................... 130.00 6 mm teflon cannula; straight insertion; 60 cm tubing x 10 with 10 needles; luer lock...................... 130.00 9 mm teflon cannula; straight insertion; 106 cm tubing x 10 with 10 needles; ................................. 130.00 9 mm teflon cannula; straight insertion; 60 cm tubing x 10 with 10 needles; ................................... 130.00 6 mm teflon cannula; straight insertion; 110 cm tubing x 10 with 10 needles; ................................. 130.00 6 mm teflon cannula; straight insertion; 60 cm tubing x 10 with 10 needles; ................................... 130.00 34 1 OP 1 OP 1 OP 1 OP 1 OP 1 OP 1 OP 1 OP 1 OP ✔ Paradigm Quick-Set MMT-387 ✔ Quick-Set MMT-390 ✔ Quick-Set MMT-391 ✔ Quick-Set MMT-392 ✔ Quick-Set MMT-393 ✔ Paradigm Quick-Set MMT-396 ✔ Paradigm Quick-Set MMT-397 ✔ Paradigm Quick-Set MMT-398 ✔ Paradigm Quick-Set MMT-399

INSULIN PUMP INFUSION SET (STEEL CANNULA) – Special Authority see SA1240 – Retail pharmacy a) Maximum of 3 packs per prescription, b) Maximum of 1 prescription per 90 days. c) Only on a prescription Note: One additional pack of infusion sets will be funded per year (Maximum of 13 packs per annum) 6 mm steel needle; 29 G; manual insertion; 60 cm tubing x 10 with 10 needles; luer lock...................... 130.00 1 OP ✔ Sure-T MMT-863 6 mm steel needle; 29 G; manual insertion; 60 cm tubing x 10 with 10 needles; ................................... 130.00 1 OP ✔ Paradigm Sure-T MMT-864 6 mm steel needle; 29 G; manual insertion; 80 cm tubing x 10 with 10 needles; luer lock...................... 130.00 1 OP ✔ Sure-T MMT-865 6 mm steel needle; 29 G; manual insertion; 80 cm tubing x 10 with 10 needles; ................................... 130.00 1 OP ✔ Paradigm Sure-T MMT-866 8 mm steel needle; 29 G; manual insertion; 60 cm tubing x 10 with 10 needles; luer lock...................... 130.00 1 OP ✔ Sure-T MMT-873 8 mm steel needle; 29 G; manual insertion; 60 cm tubing x 10 with 10 needles; ................................... 130.00 1 OP ✔ Paradigm Sure-T MMT-874 8 mm steel needle; 29 G; manual insertion; 80 cm tubing x 10 with 10 needles; luer lock...................... 130.00 1 OP ✔ Sure-T MMT-875 8 mm steel needle; 29 G; manual insertion; 80 cm tubing x 10 with 10 needles; ................................... 130.00 1 OP ✔ Paradigm Sure-T MMT-876 10 mm steel needle; 29 G; manual insertion; 60 cm tubing x 10 with 10 needles; luer lock...................... 130.00 1 OP ✔ Sure-T MMT-883 continued... Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

23


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings - effective 1 January 2013 (continued)

continued... 10 mm steel needle; 29 G; manual insertion; 60 cm tubing x 10 with 10 needles; .................................. 130.00 10 mm steel needle; 29 G; manual insertion; 80 cm tubing x 10 with 10 needles; luer lock...................... 130.00 10 mm steel needle; 29 G; manual insertion; 80 cm tubing x 10 with 10 needles; ................................... 130.00 34 1 OP 1 OP 1 OP ✔ Paradigm Sure-T MMT-884 ✔ Sure-T MMT-885 ✔ Paradigm Sure-T MMT-886

INSULIN PUMP INFUSION SET (TEFLON CANNULA, STRAIGHT INSERTION WITH INSERTION DEVICE) – Special Authority see SA1240 – Retail pharmacy a) Maximum of 3 packs per prescription, b) Maximum of 1 prescription per 90 days. c) Only on a prescription Note: One additional pack of infusion sets will be funded per year (Maximum of 13 packs per annum) 6 mm teflon cannula; straight insertion; insertion device; 45 cm pink tubing x 10 with 10 needles; ................ 130.00 1 OP ✔ Paradigm Mio MMT-921 6 mm teflon cannula; straight insertion; insertion device; 60 cm pink tubing x 10 with 10 needles ................. 130.00 1 OP ✔ Paradigm Mio MMT-923 6 mm teflon cannula; straight insertion; insertion device; 80 cm pink tubing x 10 with 10 needles; ................ 130.00 1 OP ✔ Paradigm Mio MMT-925 6 mm teflon cannula; straight insertion; insertion device; 45 cm blue tubing x 10 with 10 needles ................. 130.00 1 OP ✔ Paradigm Mio MMT-941 6 mm teflon cannula; straight insertion; insertion device; 60 cm blue tubing x 10 with 10 needles ................. 130.00 1 OP ✔ Paradigm Mio MMT-943 6 mm teflon cannula; straight insertion; insertion device; 80 cm blue tubing x 10 with 10 needles ................. 130.00 1 OP ✔ Paradigm Mio MMT-945 6 mm teflon cannula; straight insertion; insertion device; 80 cm clear tubing x 10 with 10 needles ................ 130.00 1 OP ✔ Paradigm Mio MMT-965 9 mm teflon cannula; straight insertion; insertion device; 80 cm clear tubing x 10 with 10 needles ................ 130.00 1 OP ✔ Paradigm Mio MMT-975 CALCITRIOL ❋ Cap 0.25 µg ............................................................................ 10.10 ❋ Cap 0.5 µg .............................................................................. 18.73 BEZAFIBRATE ❋ Tab 200 mg ............................................................................. 9.70 CALAMINE a) Only on a prescription b) Not in combination Crm, aqueous, BP ..................................................................... 1.77 100 100 90 ✔ Calcitriol-AFT ✔ Calcitriol-AFT ✔ Bezalip

39

47 61

100 g

✔ Pharmacy Health

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

24

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings - effective 1 January 2013 (continued)

73 77 86 89 LEVONORGESTREL ❋ Tab 750 µg ............................................................................. 12.50 TESTOSTERONE UNDECANOATE – Retail pharmacy-Specialist Inj 250 mg per ml, 4 ml ........................................................... 86.00 PENICILLIN G BENZATHINE [BENZATHINE BENZYLPENICILLIN] Inj 1.2 mega u per 2 ml – Up to 5 inj available on a PSO......... 315.00 POSACONAZOLE – Special Authority see SA1285 – Retail pharmacy Oral liq 40 mg per ml ............................................................. 761.13 2 1 10 ✔ Next Choice ✔ Reandron 1000 ✔ Bicillin LA

105 ml OP ✔ Noxafil

➽ SA1285 Special Authority for Subsidy Initial application only from a haematologist or infectious disease specialist. Approvals valid for 6 weeks for patients meeting the following criteria: Either: 1. Patient has acute myeloid leukaemia and is to be treated with high dose remission induction, re-induction or consolidation chemotherapy; or 2. Patient has received a stem cell transplant and has graft versus host disease and is on significant immunosuppressive therapy*. Renewal only from a haematologist or infectious disease specialist. Approvals valid for 6 weeks for patients meeting the following criteria: Either: 1. Patient has acute myeloid leukaemia and is to be treated with high dose remission induction, re-induction or consolidation therapy; or 2. Patient has received a stem cell transplant and has graft versus host disease and is on significant immunosuppression* and requires on going posaconazole treatment. * Graft versus host disease (GVHD) on significant immunosuppression is defined as acute GVHD, grade II to IV, or extensive chronic GVHD, or if they were being treated with intensive immunosuppressive therapy consisting of either high-dose corticosteroids (≥1 mg per kilogram of body weight per day for patients with acute GVHD or ≥0.8 mg per kilogram every other day for patients with chronic GVHD), antithymocyte globulin, or a combination of two or more immunosuppressive agents or types of treatment. 102 119 DICLOFENAC SODIUM ❋ Tab EC 25 mg .......................................................................... 4.00 ❋ Tab EC 50 mg ........................................................................ 16.00 LEVODOPA WITH CARBIDOPA (new formulation) Tab 100 mg with carbidopa 25 mg – For levodopa with carbidopa oral liquid formulation refer, page 179 .................................. 20.00 Tab long-acting 200 mg with carbidopa 50 mg ........................ 47.50 Tab 250 mg with carbidopa 25 mg ......................................... 40.00 TRAMADOL HYDROCHLORIDE Tab sustained-release 100 mg ................................................... 2.14 Tab sustained-release 150 mg ................................................... 3.21 Tab sustained-release 200 mg ................................................... 4.28 DOMPERIDONE ❋ Tab 10 mg - For domperidone oral liquid formulation refer, page 179 .................................................... 3.25 INTERFERON BETA-1-ALPHA – Special Authority see SA1062 Inj 6 million iu per 0.5 ml pen injector ................................. 1,425.10 100 500 ✔ Apo-Diclo ✔ Apo-Diclo

100 100 100 20 20 20

✔ Sinemet ✔ Sinemet CR ✔ Sinemet ✔ Tramal SR 100 ✔ Tramal SR 150 ✔ Tramal SR 200

121

131

100 4

✔ Prokinex ✔ Avonex Pen

140

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

25


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

New Listings - effective 1 January 2013 (continued)

152 DOXORUBICIN – PCT only – Specialist Inj 50 mg ................................................................................ 17.00 Inj 200 mg .............................................................................. 65.00 PHARMACY SERVICES - May only be claimed once per patient ❋ Brand switch fee........................................................................ 4.33 The Pharmacode for BSF Plendil ER is 2430231 (BSF Plendil ER Brand switch fee to be delisted 1 April 2013) 1 1 1 fee ✔ Arrow-Doxorubicin ✔ Arrow-Doxorubicin ✔ BSF Plendil ER

178

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

26

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions

Effective 1 March 2013

29 ACARBOSE – Brand switch fee payable (Pharmacode 2433486) - see page 177 for details ❋ Tab 50 mg ................................................................................ 9.82 90 ✔ Accarb ❋ Tab 100 mg ............................................................................ 15.83 90 ✔ Accarb BLOOD GLUCOSE DIAGNOSTIC TEST STRIP The number of test strips available on a prescription is restricted to 50 unless: 1) Prescribed with insulin or a sulphonylurea but are on a different prescription and endorsed accordingly;or 2) Prescribed on the same prescription as insulin or a sulphonylurea in which case the prescription is deemed to be endorsed; or 3) Prescribed for a pregnant woman with diabetes and endorsed accordingly; or 4) Prescribed for a patient on home TPN at risk of hypoglycaemia or hyperglycaemia and endorsed accordingly; or 5) Prescribed for a patient with a genetic or an acquired disorder of glucose homeostasis excluding type 1 or type 2 diabetes and metabolic syndrome and endorsed accordingly. Blood glucose test strips – Note differing brand requirements below ............................................................ 28.75 50 test OP ✔ Accu-Chek Performa 28.75 50 test OP ✔ Freestyle Optium a) Accu-Chek Performa brand: Special Authority see SA1294 – Retail pharmacy b) Freestyle Optium brand: Special Authority see SA1291 – Retail pharmacy ➽ SA1294 Special Authority for Subsidy Notes: Special Authority criteria and application details may be obtained from PHARMACs website http:/www.pharmac.govt.nz and can be sent to: PHARMAC PO Box 10 254 Facsimile: (04) 916 7571, Wellington, Email: bgstrips@pharmac.govt.nz ➽ SA1291 Special Authority for Subsidy Notes: Special Authority criteria and application details may be obtained from PHARMACs website http:/www.pharmac.govt.nz and can be sent to: PHARMAC PO Box 10 254, Facsimile: (04) 916 7571 Wellington, Email: bgstrips@pharmac.govt.nz 58 Phosphodiesterase Type 5 Inhibitors ➽ SA1086 Special Authority for Subsidy Special Authority approved by the Pulmonary Arterial Hypertension Panel Notes: Application details may be obtained from PHARMAC’s website http://www.pharmac.govt.nz or: The Coordinator, PAH Panel PHARMAC, PO Box 10-254, WELLINGTON Tel: (04) 916 7512, Fax: (04) 974 4858, Email: PAH@pharmac.govt.nz SILDENAFIL – Special Authority see SA12931086 – Retail pharmacy Tab 25 mg ............................................................................... 1.85 39.00 Tab 50 mg ................................................................................ 1.85 43.50 Tab 100 mg – For sildenafil oral liquid formulation refer, page 179 ............................................................................... 7.45 ➽ SA1293 Special Authority for Subsidy (Form name is sildenafil) Initial application – Raynaud’s phenomenon*.

31

4 4 4 4 4

✔ Silagra ✔ Viagra ✔ Silagra ✔ Viagra ✔ Silagra continued...

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

27


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 March 2013 (continued)

continued... Applications from any relevant practitioner. Approvals valid without further renewal unless notified for patients meeting the following criteria: 1 Patient has Raynaud’s phenomenon; and 2 Patient has severe digital ischaemia (defined as severe pain requiring hospital admission or with a high likelihood of digital ulceration; digital ulcers; or gangrene); and 3 Patient is following lifestyle management (proper body insulation, avoidance of cold exposure, smoking cessation support, avoidance of sympathomimetic drugs); and 4 Patient has persisting severe symptoms despite treatment with calcium channel blockers and nitrates (unless contraindicated or not tolerated). Notes 1 Sildenafil is also funded for patients with Pulmonary Arterial Hypertension who are approved by the Pulmonary Arterial Hypertension Panel (an application must be made to the Panel). Application details may be obtained from: The Coordinator, PAH Panel PHARMAC, PO Box 10 254, Wellington Phone: (04) 916 7512 Facsimile: (04) 974 4858 Email: PAH@pharmac.govt.nz 2 Indications marked with an * are Unapproved Indications. ETHINYLOESTRADIOL WITH LEVONORGESTREL ❋ Tab 30 µg with levonorgestrel 150 µg and 7 inert tab................. 2.45 84 a) Brand switch fee payable (Pharmacode 2405865) - see page 177 for details b) Up to 84 tab available on a PSO ✔ Ava 30 ED

72

90

ETHAMBUTOL HYDROCHLORIDE – No patient co-payment payable (addition of S29 ) Tab 100 mg ............................................................................ 48.01 56 ✔ Myambutol S29 Tab 400 mg ........................................................................... 49.34 56 ✔ Myambutol S29

92

LAMIVUDINE – Special Authority see SA0832 – Retail pharmacy Tab 100 mg – Brand switch fee payable (Pharmacode 2433257) - see page 177 for details ............ 32.50

28

✔ Zetlam

98

ZIDOVUDINE [AZT] WITH LAMIVUDINE – Special Authority see SA1025– Retail pharmacy – Brand switch fee payable (Pharmacode 2433494) - see page 177 for details Note: zidovudine [AZT] with lamivudine (combination tablets) counts as two anti-retroviral medications for the purposes of the anti-retroviral Special Authority. Tab 300 mg with lamivudine 150 mg ....................................... 63.50 60 ✔ Alphapharm ENTACAPONE – Brand switch fee payable (Pharmacode 2433249) - see page 177 for details s Tab 200 mg ............................................................................ 47.92 100 ✔ Entapone PHARMACY SERVICES – May only be claimed once per patient ❋ Brand switch fee........................................................................ 4.33 The Pharmacode for BSF CareSens N is 2423138 (BSF CareSens N Brand switch fee to be delisted 1 March July 2013) ❋ Brand switch fee........................................................................ 4.33 The Pharmacode for BSF CareSens II is 2423146 (BSF CareSens II Brand switch fee to be delisted 1 March July 2013) ❋ Brand switch fee........................................................................ 4.33 The Pharmacode for BSF CareSens N POP is 2423154 (BSF CareSens N POP Brand switch fee to be delisted 1 March July 2013) 1 fee 1 fee 1 fee ✔ BSF CareSens N ✔ BSF CareSens II ✔ BSF CareSens N POP

119 180

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

28

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 February 2013

52 CANDESARTAN – Special Authority see SA1223 – Retail pharmacy Brand switch fee payable (Pharmacode 2426781) - see page 177 for details Tab 4 mg .................................................................................. 4.13 Tab 8 mg .................................................................................. 6.10 Tab 16 mg .............................................................................. 10.18 Tab 32 mg ............................................................................. 17.66 90 90 90 90 ✔ Candestar ✔ Candestar ✔ Candestar ✔ Candestar

191

Paediatric Products for Children Awaiting Liver Transplant ➽ SA1098 Special Authority for Subsidy Initial application only from a dietitian, relevant specialist or vocationally registered general practitioner. Approvals valid for 3 years where the patient is a child (up to 18 years) who is awaiting liver transplant requires a liver transplant. Renewal only from a dietitian, relevant specialist, vocationally registered general practitioner or general practitioner on the recommendation of a dietitian, relevant specialist or vocationally registered general practitioner. Approvals valid for 3 years for applications meeting the following criteria: Both: 1 The treatment remains appropriate and the patient is benefiting from treatment; and 2 General Practitioners must include the name of the dietitian, relevant specialist or vocationally registered general practitioner and date contacted.

205

HIGH FAT LOW CARBOHYDRATE FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND CARBOHYDRATE – Special Authority see SA1197 – Retail pharmacy Powder (vanilla) ...................................................................... 35.50 300 g OP ✔ KetoCal

Effective 1 January 2013

32 INSULIN PUMP – Special Authority see SA1237 – Retail pharmacy a) Only on a prescription b) Maximum of 1 insulin pump per prescription c) Maximum of 1 insulin pump per patient each four year period Flat panel, high contrast screen; compatible with standard luer lock infusion sets; waterproof at 12 feet for 24 hours; 0.025 u/hour basal rate; continuous glucose monitoring (CGM) enabled; Min basal rate 0.025 U/h; blue colour............................ 4,500.00 Flat panel, high contrast screen; compatible with standard luer lock infusion sets; waterproof at 12 feet for 24 hours; 0.025 u/hour basal rate; continuous glucose monitoring (CGM) enabled Min basal rate 0.025 U/h; silver colour .......................... 4,500.00 Flat panel, high contrast screen; compatible with standard luer lock infusion sets; waterproof at 12 feet for 24 hours; 0.025 u/hour basal rate; continuous glucose monitoring (CGM) enabled Min basal rate 0.025 U/h; pink colour............................ 4,500.00 Flat panel, high contrast screen; compatible with standard luer lock infusion sets; waterproof at 12 feet for 24 hours; 0.025 u/hour basal rate; continuous glucose monitoring (CGM) enabled Min basal rate 0.025 U/h; green colour ......................... 4,500.00 Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

1

✔ Animas Vibe

1

✔ Animas Vibe

1

✔ Animas Vibe

1

✔ Animas Vibe continued...

❋ Three months or six months, as applicable, dispensed all-at-once

29


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 January 2013 (continued)

continued... Flat panel, high contrast screen; compatible with standard luer lock infusion sets; waterproof at 12 feet for 24 hours; 0.025 u/hour basal rate; continuous glucose monitoring (CGM) enabled Min basal rate 0.025 U/h; black colour .......................... 4,500.00 34

1

✔ Animas Vibe

INSULIN PUMP INFUSION SET (STEEL CANNULA) – Special Authority see SA1240 – Retail Pharmacy a) Maximum of 3 packs per prescription, b) Maximum of 1 prescription per 90 days. c) Only on a prescription Note: One additional pack of infusion sets will be funded per year (Maximum of 13 packs per annum) 6 mm metal steel cannula; straight insertion; 60 cm grey line x 10 with 10 needles ................................. 130.00 1 OP ✔ Contact-D 8 mm metal steel cannula; straight insertion; 60 cm grey line x 10 with 10 needles.. ............................... 130.00 1 OP ✔ Contact-D 8 mm metal steel cannula; straight insertion; 110 cm grey line x 10 with 10 needles ............................... 130.00 1 OP ✔ Contact-D INSULIN PUMP INFUSION SET (TEFLON CANNULA, STRAIGHT INSERTION WITH INSERTION DEVICE) – Special Authority see SA1240 – Retail Pharmacy a) Maximum of 3 packs per prescription, b) Maximum of 1 prescription per 90 days. c) Only on a prescription Note: One additional pack of infusion sets will be funded per year (Maximum of 13 packs per annum) Teflon cannula straight insertion 6 mm; with auto injector; 6 mm Teflon cannula; straight insertion; Insertion device; 60 cm grey line x 10 with 10 needles ............................................ 140.00 1 OP ✔ Inset II Teflon cannula straight insertion 6 mm; with auto injector; 6 mm Teflon cannula; straight insertion; Insertion device; 60 cm pink line x 10 with 10 needles ............................................ 140.00 1 OP ✔ Inset II Teflon cannula straight insertion 6 mm; with auto injector; 6 mm Teflon cannula; straight insertion; Insertion device; 60 cm blue line x 10 with 10 needles ............................................ 140.00 1 OP ✔ Inset II Teflon cannula straight insertion 9 mm; with auto injector; 9 mm Teflon cannula; straight insertion; Insertion device; 60 cm grey line x 10 with 10 needles ............................................ 140.00 1 OP ✔ Inset II Teflon cannula straight insertion 9 mm; with auto injector; 9 mm Teflon cannula; straight insertion; Insertion device; 60 cm pink line x 10 with 10 needles ............................................ 140.00 1 OP ✔ Inset II Teflon cannula straight insertion 9 mm; with auto injector; 9 mm Teflon cannula; straight insertion; Insertion device; 60 cm blue line x 10 with 10 needles ............................................ 140.00 1 OP ✔ Inset II Teflon cannula straight insertion 6 mm; with auto injector; 6 mm Teflon cannula; straight insertion; Insertion device;110 cm grey line x 10 with 10 needles ............................................ 140.00 1 OP ✔ Inset II Teflon cannula straight insertion 9 mm; with auto injector; 9 mm Teflon cannula; straight insertion; Insertion device; 110 cm grey line x 10 with 10 needles ............................................ 140.00 1 OP ✔ Inset II

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply

34

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

30


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Restrictions - effective 1 January 2013 (continued)

34 INSULIN PUMP INFUSION SET (TEFLON CANNULA, ANGLE INSERTION) – Special Authority see SA1240 – Retail Pharmacy a) Maximum of 3 packs per prescription, b) Maximum of 1 prescription per 90 days. c) Only on a prescription Note: One additional pack of infusion sets will be funded per year (Maximum of 13 packs per annum) Teflon cannula angle insertion 13 mm; 13 mm Teflon cannula; angle insertion; 60 cm grey line x 5 with 10 needles ................................... 120.00 1 OP ✔ Comfort Short Teflon cannula angle insertion 17 mm; 17 mm Teflon cannula; angle insertion; 60 cm grey line x 5 with 10 needles ................................... 120.00 1 OP ✔ Comfort Teflon cannula angle insertion 17 mm; 17 mm Teflon cannula; angle insertion; 110 cm grey line x 5 with 10 needles ................................. 120.00 1 OP ✔ Comfort INSULIN PUMP INFUSION SET (TEFLON CANNULA, ANGLE INSERTION WITH INSERTION DEVICE) – Special Authority see SA1240 – Retail Pharmacy a) Maximum of 3 packs per prescription, b) Maximum of 1 prescription per 90 days. c) Only on a prescription Note: One additional pack of infusion sets will be funded per year (Maximum of 13 packs per annum) Teflon cannula angle insertion 13 mm with auto injector; 13 mm Teflon cannula; angle insertion; Insertion device; 60 cm grey line x 10 with 10 needles ..... 140.00 1 OP ✔ Inset 30 Teflon cannula angle insertion 13 mm with auto injector; 13 mm Teflon cannula; angle insertion; Insertion device; 60 cm pink line x 10 with 10 needles ..... 140.00 1 OP ✔ Inset 30 Teflon cannula angle insertion 13 mm with auto injector; 13 mm Teflon cannula; angle insertion; Insertion device; 60 cm blue line x 10 with 10 needles ..... 140.00 1 OP ✔ Inset 30 Teflon cannula angle insertion 13 mm with auto injector; 13 mm Teflon cannula; angle insertion; Insertion device; 110 cm grey line x 10 with 10 needles ... 140.00 1 OP ✔ Inset 30 FELODIPINE ❋ Tab long-acting 5 mg – Brand switch fee payable (Pharmacode 2430231) - see page 177 for details .................. 3.10 ❋ Tab long-acting 10 mg – Brand switch fee payable (Pharmacode 2430231) - see page 177 for details .................. 4.60

34

54 73

30 30

✔ Plendil ER ✔ Plendil ER

Antiandrogen Oral Contraceptives Prescribers may code prescriptions “contraceptive” (code “O”) when used as indicated for contraception. The period of supply and prescription charge will be as per other contraceptives, as follows: • $3.00 $5.00 prescription charge (patient co-payment) will apply. • prescription may be written for up to six months supply. Prescriptions coded in any other way are subject to the non-contraceptive prescription charges, and the noncontraceptive period of supply. ie. Prescriptions may be written for up to three months supply BRIMONIDINE TARTRATE ❋ Eye Drops 0.2% – Brand switch fee payable (Pharmacode 2425823) - see page 177 for details .................... 6.45

176

5 ml OP

✔ Arrow-Brimonidine

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

31


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturer’s Price

Effective 1 March 2013

30 BLOOD KETONE DIAGNOSTIC TEST METER ( subsidy) Meter funded for the purposes of blood ketone diagnostics only. Patient has had one or more episodes of ketoacidosis and is at risk of future episodes. Only one meter per patient will be subsidised every 5 years. Meter ...................................................................................... 40.00 1 ✔ Freestyle Optium KETONE BLOOD BETA-KETONE ELECTRODES – Maximum of 20 strip per prescription ( subsidy) Test strip – Not on a BSO ........................................................ 15.50 10 strip OP ✔ Freestyle Optium Ketone BLOOD GLUCOSE DIAGNOSTIC TEST STRIP ( subsidy) The number of test strips available on a prescription is restricted to 50 unless: 1) Prescribed with insulin or a sulphonylurea but are on a different prescription and endorsed accordingly;or 2) Prescribed on the same prescription as insulin or a sulphonylurea in which case the prescription is deemed to be endorsed; or 3) Prescribed for a pregnant woman with diabetes and endorsed accordingly; or 4) Prescribed for a patient on home TPN at risk of hypoglycaemia or hyperglycaemia and endorsed accordingly; or 5) Prescribed for a patient with a genetic or an acquired disorder of glucose homeostasis excluding type 1 or type 2 diabetes and metabolic syndrome and endorsed accordingly. Blood glucose test strips – Note differing brand requirements below ............................................................. 28.75 50 test OP ✔ Accu-Chek Performa 28.75 50 test OP ✔ Freestyle Optium a) Accu-Chek Performa brand: Special Authority see SA1294 – Retail pharmacy b) Freestyle Optium brand: Special Authority see SA1291 – Retail pharmacy DANTHRON WITH POLOXAMER – Only on a prescription ( subsidy) Note: Only for the prevention or treatment of constipation in the terminally ill. Oral liq 25 mg with poloxamer 200 mg per 5 ml ....................... 21.30 300 ml Oral liq 75 mg with poloxamer 1 g per 5 ml .............................. 43.60 300 ml BETAMETHASONE VALERATE ( subsidy) ❋ Crm 0.1% .................................................................................. 3.50 ❋ Oint 0.1% .................................................................................. 3.50 CLOBETASOL PROPIONATE ( subsidy) ❋ Crm 0.05% ................................................................................ 3.68 ❋ Oint 0.05% ................................................................................ 3.68 BETAMETHASONE VALERATE ( subsidy) ❋ Scalp app 0.1% ........................................................................ 7.75 CLOBETASOL PROPIONATE ( subsidy) ❋ Scalp app 0.05% ....................................................................... 6.96 TRIMETHOPRIM ( subsidy) ❋ Tab 300 mg – Up to 30 tab available on a PSO .......................... 9.28 DICLOFENAC SODIUM ( subsidy) ❋ Tab EC 50 mg ........................................................................... 1.60 (2.13) 50 g OP 50 g OP 30 g OP 30 g OP

30

31

37

✔ Pinorax ✔ Pinorax Forte ✔ Beta Cream ✔ Beta Ointment ✔ Dermol ✔ Dermol

62

62

68 68 88 102

100 ml OP ✔ Beta Scalp 30 ml OP 50 50 Diclofenac Sandoz ✔ Dermol ✔ TMP

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

32

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturers Price - effective 1 March 2013 (continued)

118 BACLOFEN ( subsidy) ❋ Tab 10 mg – For baclofen oral liquid formulation refer, page 179 .............................................................................. 5.10 DOMPERIDONE ( subsidy) ❋ Tab 10 mg – For domperidone oral liquid formulation refer, page 179 ............................................................................... 3.25 (11.99) DOXORUBICIN – PCT only – Specialist ( subsidy) Inj 1 mg for ECP ........................................................................ 0.37 TAMOXIFEN CITRATE ( subsidy) ❋ Tab 10 mg .............................................................................. 17.50 PROMETHAZINE HYDROCHLORIDE ( subsidy) ❋‡ Oral liq 5 mg per 5 ml.............................................................. 2.79 (3.10)

100

✔ Pacifen

131

100 Motilium 1 mg 100 100 ml Promethazine Winthrop Elixir ✔ Baxter ✔ Genox

151 160 166

Effective 1 February 2013

38 MICONAZOLE ( subsidy) Oral gel 20 mg per g ................................................................. 4.95 (8.70) PROTAMINE SULPHATE ( price) ❋ Inj 10 mg per ml, 5 ml ............................................................. 22.40 (101.61) BEZAFIBRATE ( subsidy) ❋ Tab 200 mg .............................................................................. 9.70 NADOLOL ( subsidy) ❋ Tab 40 mg .............................................................................. 15.57 ❋ Tab 80 mg .............................................................................. 23.74 DILTIAZEM HYDROCHLORIDE ( subsidy) ❋ Cap long-acting 120 mg ............................................................ 1.91 (4.34) ❋ Cap long-acting 180 mg ........................................................... 2.86 (6.50) ❋ Cap long-acting 240 mg ............................................................ 3.81 (8.67) ERYTHROMYCIN LACTOBIONATE ( subsidy) Inj 1 g ..................................................................................... 16.00 40 g OP Daktarin 10 Artex 90 100 100 30 Cardizem CD 30 Cardizem CD 30 Cardizem CD 1 ✔ Erythrocin IV ✔ Fibalip ✔ Apo-Nadolol ✔ Apo-Nadolol

44 47 54 55 85

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

33


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturers Price - effective 1 February 2013 (continued)

85 AZITHROMYCIN ( subsidy) Maximum of 5 days treatment per prescription; can be waived by endorsement for the following patients: For Endorsement, patient has either: i) Received a lung transplant and requires treatment or prophylaxis for bronchiolitis obliterans syndrome *;or ii) Cystic fibrosis and has chronic infection with Pseudomonas aeruginosa or Pseudomonas related gram negative organisms * Indications marked with * are Unapproved Indications Tab 500 mg – Up to 8 tab available on a PSO ............................ 1.25 2 OP ✔ Arrow-Azithromycin PAMIDRONATE DISODIUM ( subsidy) Inj 3 mg per ml, 10 ml ............................................................ 16.00 (37.50) Inj 6 mg per ml, 10 ml ............................................................ 32.00 (75.00) Inj 9 mg per ml, 10 ml ............................................................ 48.00 (112.50) 1 Pamisol 1 Pamisol 1 Pamisol

115

125

165

MOCLOBEMIDE Note: There is a significant cost differential between moclobemide and fluoxetine (moclobemide being about three times more expensive). For depressive syndromes it is therefore more cost-effective to start treatment with fluoxetine first before considering prescribing moclobemide. ❋ Tab 150 mg ( subsidy) .......................................................... 81.83 500 ✔ Apo-Moclobemide ❋ Tab 300 mg ( subsidy) .......................................................... 29.51 100 ✔ Apo-Moclobemide DEXTROCHLORPHENIRAMINE MALEATE ( price) ❋ Tab 2 mg .................................................................................. 1.01 (5.99) 2.02 (8.40) GLYCERIN WITH SODIUM SACCHARIN – Only in combination ( subsidy) Only in combination with Ora-Plus. Suspension ............................................................................. 35.50 GLYCERIN WITH SUCROSE – Only in combination ( subsidy) Only in combination with Ora-Plus. Suspension ............................................................................. 35.50 METHYLCELLULOSE ( subsidy) Suspension – Only in combination ........................................... 35.50 20 Polaramine 40 Polaramine

183

473 ml

✔ Ora-Sweet SF

183

473 ml 473 ml

✔ Ora-Sweet ✔ Ora-Plus

184 184 184

METHYLCELLULOSE WITH GLYCERIN AND SODIUM SACCHARIN – Only in combination ( subsidy) Suspension ............................................................................. 35.50 473 ml ✔ Ora-Blend SF METHYLCELLULOSE WITH GLYCERIN AND SUCROSE – Only in combination ( subsidy) Suspension ............................................................................ 35.50 473 ml ✔ Ora-Blend

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

34

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Subsidy and Manufacturers Price - effective 1 January 2013

28 77 LANSOPRAZOLE ( subsidy) ❋ Cap 15 mg ................................................................................ 2.00 ❋ Cap 30 mg ................................................................................ 2.32 PREDNISOLONE SODIUM PHOSPHATE ( subsidy) ❋ Oral liq 5 mg per ml – Up to 30 ml available on a PSO .............. 10.45 Restricted to children under 12 years of age. NEVIRAPINE – Special Authority see SA1025 – Retail pharmacy ( subsidy) Tab 200 mg ............................................................................ 95.94 (319.80) LISURIDE HYDROGEN MALEATE ( subsidy) s Tab 200 µg ............................................................................ 25.00 PETHIDINE HYDROCHLORIDE ( subsidy) a) Only on a controlled drug form b) No patient co-payment payable c) Safety medicine; prescriber may determine dispensing frequency Tab 50 mg ................................................................................ 3.95 Tab 100 mg .............................................................................. 5.80 28 28 30 ml OP ✔ Lanzol Relief ✔ Lanzol Relief ✔ Redipred

97

60 Viramune 30 ✔ Dopergin

119 123

10 10

✔ PSM ✔ PSM

124

AMITRIPTYLINE – Safety medicine; prescriber may determine dispensing frequency ( subsidy) Tab 10 mg ............................................................................... 1.66 50 (2.77) Amirol PHENOBARBITONE ( subsidy) For phenobarbitone oral liquid refer, page 185 ❋ Tab 15 mg .............................................................................. 28.00 ❋ Tab 30 mg .............................................................................. 29.00 PIZOTIFEN ( subsidy) ❋ Tab 500 µg ............................................................................. 23.21 CARBOPLATIN – PCT only – Specialist ( subsidy) Inj 1 mg for ECP ........................................................................ 0.13 CISPLATIN – PCT only – Specialist ( susidy) Inj 1 mg per ml, 50 ml ............................................................. 15.00 Inj 1 mg per ml, 100 ml .......................................................... 21.00 MEGESTROL ACETATE – Retail pharmacy-Specialist ( subsidy) Tab 160 mg ............................................................................ 51.55 (57.92) CYCLOSPORIN ( subsidy) Cap 25 mg ............................................................................. 44.63 Cap 50 mg .............................................................................. 88.91 Cap 100 mg ......................................................................... 177.81

129 131 148 148

500 500 100 1 mg 1 1 30

✔ PSM ✔ PSM ✔ Sandomigran ✔ Baxter ✔ DBL Cisplatin ✔ DBL Cisplatin

160 165

Megace 50 50 50 ✔ Neoral ✔ Neoral ✔ Neoral

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

35


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to General Rules

Effective 1 January 2013

9 Patient costs Community Pharmaceutical costs met by the Government Most of the cost of a subsidised prescription Community Pharmaceutical is met by the Government through the Pharmaceutical Budget. The Government pays a subsidy for the Community Pharmaceutical to Contractors, and a fee covering distribution and pharmacy dispensing services. The subsidy paid to Contractors does not necessarily represent the final cost to Government of subsidising a particular Community Pharmaceutical. The final cost will depend on the nature of PHARMAC’s contractual arrangements with the supplier. Fully subsidised medicines are identified with a √ in the product’s Schedule listing. SALBUTAMOL Aerosol inhaler 100 µg per dose ................................................ 3.80 ✔ Fully subsidised brand (6.00) Higher priced brand Pharmaceutical Co-Payments Some Community Pharmaceutical costs are met by the patient. Generally a patient pays a prescription charge. In addition a patient will sometimes pay a manufacturer’s surcharge, after hours service fee and any special packaging fee. PRESCRIPTION CHARGE From 1 September 2008 1 January 2013, everyone who is eligible for publicly funded health and disability services should in most circumstances pay only $3 $5 for subsidised medicines. All prescriptions from a public hospital, a midwife and a Family Planning Clinic are covered for $3 $5 co-payments. Prescriptions from the following providers are approved for $3 $5 co-payments on subsidised medicines if they meet the specified criteria: • After Hours Accident and Medical Services with a DHB or a PHO contract. • Youth Health Clinics with a DHB or a PHO contract. • Dentists who write a prescription that relates to a service being provided under a DHB contract. • Private specialists (for example, opthalmologists and orthopaedics) who write a prescription for a patient receiving a publicly funded service contracted by the DHB. • General practitioners who write a prescription during normal business hours to a person who is not enrolled in the general practice provided the person is eligible for publicly funded health and disability services and the general practice is part of a PHO. • Hospices that have a contract with a DHB. Patients can check whether they are eligible for publicly funded health and disability services by referring to the Eligibility Direction on the Ministry of Health’s website. To check if a medicine is fully subsidised, refer to the Pharmaceutical Schedule on PHARMAC’s website or ask your pharmacist or general practitioner. DHBs have a list of eligible providers in their respective regions. Any provider/prescriber not specifically listed by a DHB as an approved provider/prescriber should be regarded as not approved. NOTE: Information sourced from Ministry of Health Website, for more information please visit www.moh.govt.nz

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

36

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Brand Name

Effective 1 January 2013

148 CISPLATIN – PCT only – Specialist Inj 1 mg per ml, 50 ml ............................................................. 15.00 Inj 1 mg per ml, 100 ml .......................................................... 21.00 1 1 ✔ Mayne DBL Cisplatin ✔ Mayne DBL Cisplatin

Changes to PSO

Effective 1 January 2013

209 PENICILLIN G BENZATHINE [BENZATHINE BENZYLPENICILLIN] ✔ Inj 1.2 mega u per 2 ml 5

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

37


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Changes to Section I

Effective 1 February 2013

216 INFLUENZA VACCINE – Hospital pharmacy [Xpharm] A) is available 1 March until vaccine supplies are exhausted each year for patients who meet the following criteria, as set by the Ministry of Health PHARMAC: a) all people 65 years of age and over; b) people under 65 years of age with: i) the following cardiovascular disease: 1) ischaemic heart disease, 2) congestive heart disease, 3) rheumatic heart disease, 4) congenital heart disease, or 5) cerebo-vascular disease; ii) the following chronic respiratory disease: 1) asthma, if on a regular preventative therapy, or 2) other chronic respiratory disease with impaired lung function; iii)diabetes; iv)chronic renal disease; v) any cancer, excluding basal and squamous skin cancers if not invasive; vi)the following other conditions: a) autoimmune disease, b) immune suppression, c) HIV, d) transplant recipients, e) neuromuscular and CNS diseases, f) haemoglobinopathies, g) children on long term aspirin, or h) pregnancy. c) people under 18 years of age living within the boundaries of the Canterbury District Health Board. The following conditions are excluded from funding: a) asthma not requiring regular preventative therapy, b) hypertension and/or dyslipidaemia without evidence of end-organ disease. B) Doctors are the only Contractors entitled to claim payment from the Funder for the supply of influenza vaccine to patients eligible under the above criteria for subsidised immunisation and they may only do so in respect of the influenza vaccine listed in the Pharmaceutical Schedule. C) Individual DHBs may fund patients over and above the above criteria. The claiming process for these additional patients should be determined between the DHB and Contractor. D) Influenza Vaccine does not fall within the definition Community Pharmaceutical as it is not funded directly from the Pharmaceutical Budget. Pharmacists are unable to claim for the dispensing of influenza vaccine from the Funder. D) Stock of the seasonal influenza vaccine is typically available from February until late July with suppliers being required to ensure supply until at least 30 June. Exact start and end dates for each season will be notified each year.

Effective 1 January 2013

217 DIPHTHERIA, TETANUS AND PERTUSSIS VACCINE – Hospital pharmacy [Xpharm] For children aged 11 years old and pregnant women between gestational weeks 28 and 38 during epidemics Inj 0.5 ml................................................................................... 0.00 1 ✔ Boostrix

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

38

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items

Effective 1 March 2013

29 31 ACARBOSE ❋ Tab 50 mg ................................................................................ 9.82 ❋ Tab 100 mg ............................................................................ 15.83 90 90 ✔ Glucobay ✔ Glucobay

BLOOD GLUCOSE DIAGNOSTIC TEST STRIP The number of test strips available on a prescription is restricted to 50 unless: 1. Prescribed with insulin or a sulphonylurea but are on a different prescription and the prescription is endorsed accordingly; or 2. Prescribed on the same prescription as insulin or a sulphonylurea in which case the prescription is deemed to be endorsed; or 3. Prescribed for a pregnant woman with diabetes and endorsed accordingly; or 4. Prescribed for a patient on home TPN at risk of hypoglycaemia or hyperglycaemia and endorsed accordingly; or 5. Prescribed for a patient with a genetic or an acquired disorder of glucose homeostasis excluding type 1 or type 2 diabetes and metabolic syndrome and endorsed accordingly. Blood glucose test strips ......................................................... 21.65 50 test OP ✔ FreeStyle Lite Blood glucose test strips × 50 and lancets × 5 ...................... 19.10 50 test OP ✔ On Call Advanced MACROGOL 3350 – Special Authority see SA0891 – Retail pharmacy Powder 13.125 g, sachets – Maximum of 60 sach per prescription ................................................................... 10.00 (18.14) CHLORHEXIDINE GLUCONATE Mouthwash 0.2% ...................................................................... 2.68 (3.87) CILAZAPRIL ❋ Tab 0.5 mg .............................................................................. 0.95 ENALAPRIL ❋ Tab 5 mg .................................................................................. 1.07 ❋ Tab 10 mg ................................................................................ 1.32 ❋ Tab 20 mg – For enalapril oral liquid formulation refer, page 179 ............................................................................... 1.72 CICLOPIROX OLAMINE a) Only on a prescription b) Not in combination Nail soln 8% .............................................................................. 4.11 (19.85) LAMIVUDINE – Special Authority see SA0832– Retail pharmacy Tab 100 mg ............................................................................ 32.50 (143.00)

36

30 Movicol 200 ml OP Rivacol 30 9 90 90 ✔ Zapril ✔ Arrow-Enalapril ✔ Arrow-Enalapril ✔ Arrow-Enalapril

37

50 50 60

3 g OP Batrafen 28 Zeffix

92

98

ZIDOVUDINE [AZT] WITH LAMIVUDINE – Special Authority see SA1025 – Retail pharmacy Zidovudine [AZT] with lamivudine counts as two anti-retroviral medications for the purposes of the anti-retroviral Special Authority. Tab 300 mg with lamivudine 150 mg ....................................... 63.50 60 (667.20) Combivir Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber. ❋ Three months or six months, as applicable, dispensed all-at-once

39


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items – effective 1 March 2013 (continued)

103 119 123 LEFLUNOMIDE ❋ Tab 10 mg .............................................................................. 55.00 ❋ Tab 20 mg .............................................................................. 76.00 ENTACAPONE s Tab 200 mg ............................................................................ 47.92 (116.00) OXYCODONE HYDROCHLORIDE a) Only on a controlled drug form b) See prescribing guideline below c) No patient co-payment payable d) Safety medicine; prescriber may determine dispensing frequency Inj 10 mg per ml, 1 ml ............................................................... 9.93 Inj 10 mg per ml, 2 ml ............................................................. 19.87 SODIUM CROMOGLYCATE Aerosol inhaler, 5 mg per dose CFC-free .................................. 28.07 FLUOROMETHOLONE ❋ Eye drops 0.1% ......................................................................... 3.80 (4.05) PHARMACY SERVICES – may only be claimed once per patient Brand switch fee........................................................................ 4.33 30 30 100 Comtan ✔ AFT-Leflunomide ✔ AFT-Leflunomide

5 5

✔ OxyNorm ✔ OxyNorm

170 174 177

112 dose OP ✔ Vicrom 5 ml OP FML 1 fee ✔ BSF Ava 30 ED

Effective 1 February 2013

61 CALAMINE a) Only on a prescription b) Not in combination Crm, aqueous, BP ..................................................................... 1.77 (2.78) AMOXYCILLIN CLAVULANATE Grans for oral liq amoxycillin 125 mg with potassium clavulanate 31.25 mg per 5 ml – Up to 200 ml available on a PSO............ 1.61 (2.20) Grans for oral liq amoxycillin 250 mg with potassium clavulanate 62.5 mg per 5 ml – Up to 200 ml available on a PSO.............. 2.19 (3.85) AURANOFIN Tab 3 mg ................................................................................ 68.99 FLUTICASONE PROPIONATE Metered aqueous nasal spray, 50 µg per dose ........................... 2.30 PHARMACY SERVICES – May only be claimed once per patient ❋ Brand switch fee........................................................................ 4.33

100 g healthE

86

100 ml Curam 100 ml Curam 60 ✔ Ridaura

103 171

120 dose OP ✔ Flixonase Hayfever & Allergy 1 fee ✔ BSF Candestar

180

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

40

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items – effective 1 January 2013

30 METFORMIN HYDROCHLORIDE ❋ Tab immediate-release 500 mg.................................................. 6.15 500 ✔ Apotex ❋ Tab immediate-release 850 mg.................................................. 5.05 250 ✔ Apotex Note – Apotex tab immediate-release 500 mg, 1,000 mg tab pack, and 850 mg, 500 tab pack, remain subsidised. DABIGATRAN Cap 110 mg .......................................................................... 148.00 60 ✔ Pradaxa Cap 150 mg .......................................................................... 148.00 60 ✔ Pradaxa Note – these are the bottles Pharmacode 2377578 (110 mg cap) and 2377551 (150 mg cap) ATORVASTATIN ❋ Tab 10 mg ................................................................................ 0.84 (18.32) ❋ Tab 20 mg ................................................................................ 1.39 (26.70) ❋ Tab 40 mg ................................................................................ 2.44 (37.02) ❋ Tab 80 mg ................................................................................ 5.41 (110.50) 50 PHENTOLAMINE MESYLATE ❋ Inj 10 mg per ml, 1 ml ............................................................. 17.97 (31.65) FELODIPINE ❋ Tab long-acting 5 mg ................................................................ 9.30 ❋ Tab long-acting 10 mg ............................................................ 13.80 NANDROLONE DECANOATE Inj 50 mg per ml, 1 ml ............................................................. 21.16 TESTOSTERONE UNDECANOATE – Retail pharmacy- Specialist Cap 40 mg .............................................................................. 51.95 5 Regitine 90 90 1 ✔ Felo 5 ER ✔ Felo 10 ER ✔ Deca-Durabolin Orgaject S29 ✔ Arrow-Testosterone ✔ Solu-Medrol ✔ Solu-Medrol 30 30 30 30 ✔ Dr Reddy’s Atorvastatin Lipitor ✔ Dr Reddy’s Atorvastatin Lipitor ✔ Dr Reddy’s Atorvastatin Lipitor ✔ Dr Reddy’s Atorvastatin Lipitor

44

48

54

76

77 77

100

METHYLPREDNISOLONE SODIUM SUCCINATE – Retail pharmacy – Specialist Inj 40 mg per ml, 1 ml ........................................................... 151.40 25 Inj 62.5 mg per ml, 2 ml ........................................................ 412.59 25 FLUCLOXACILLIN SODIUM Cap 250 mg – Up to 30 caps available on a PSO ..................... 22.00 (32.00) Cap 500 mg ........................................................................... 74.00 (110.00) 250

86

AFT 500 AFT

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

41


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Delisted Items – effective 1 January 2013 (continued)

152 DOCETAXEL – PCT only - Specialist Inj 20 mg .............................................................................. 460.00 Inj 80 mg ........................................................................... 1,650.00 LETROZOLE ❋ Tab 2.5 mg .............................................................................. 4.85 (9.00) PHARMACY SERVICES – May only be claimed once per patient ❋ Brand switch fee........................................................................ 4.33 1 1 30 Letara 1 fee ✔ BSF ArrowBrimonidine ✔ Taxotere ✔ Taxotere

161

178

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

42

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted

Effective 1 April 2013

27 28 50 FAMOTIDINE ❋ Tab 40 mg .............................................................................. 11.35 LANSOPRAZOLE ❋ Cap 15 mg ................................................................................ 2.00 ❋ Cap 30 mg ................................................................................ 2.32 LISINOPRIL Tab 5 mg .................................................................................. 1.19 Tab 10 mg ................................................................................ 1.36 Tab 20 mg ................................................................................ 1.63 NEVIRAPINE – Special Authority see SA1025 – Retail pharmacy Tab 200 mg ............................................................................ 95.94 (319.80) 250 28 28 30 30 30 60 Viramune ✔ Famox ✔ Lanzol Relief ✔ Lanzol Relief ✔ Arrow-Lisinopril ✔ Arrow-Lisinopril ✔ Arrow-Lisinopril

97

124

AMITRIPTYLINE – Safety medicine; prescriber may determine dispensing frequency Tab 10 mg ............................................................................... 1.66 50 (2.77) MEGESTROL ACETATE – Retail pharmacy-Specialist Tab 160 mg ............................................................................ 51.55 (57.92) PHARMACY SERVICES – May only be claimed once per patient ❋ Brand switch fee........................................................................ 4.33 30

Amirol

160

Megace 1 fee ✔ BSF Plendil ER

178

Effective 1 May 2013

38 MICONAZOLE Oral gel 20 mg per g ................................................................. 4.95 (8.70) DILTIAZEM HYDROCHLORIDE Cap long-acting 120 mg ............................................................ 1.91 (4.34) Cap long-acting 180 mg ........................................................... 2.86 (6.50) Cap long-acting 240 mg ............................................................ 3.81 (8.67) SILDENAFIL – Special Authority see SA1086 – Retail pharmacy Tab 25 mg .............................................................................. 39.00 Tab 50 mg .............................................................................. 43.50 Tab 100 mg – For sildenafil oral liquid formulation refer, page 179 ............................................................................. 47.00 40 g OP Daktarin 30 Cardizem CD 30 Cardizem CD 30 Cardizem CD 4 4 4 ✔ Viagra ✔ Viagra ✔ Viagra

55

58

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

43


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted – effective 1 May 2013 (continued)

85 AZITHROMYCIN Maximum of 5 days treatment per prescription; can be waived by endorsement for the following patients: For Endorsement, patient has either: i) Received a lung transplant and requires treatment or prophylaxis for bronchiolitis obliterans syndrome *;or ii) Cystic fibrosis and has chronic infection with Pseudomonas aeruginosa or Pseudomonas related gram negative organisms * Indications marked with * are Unapproved Indications Tab 500 mg – Up to 8 tab available on a PSO ............................ 1.25 2 OP ✔ Arrow-Azithromycin PAMIDRONATE DISODIUM Inj 3 mg per ml, 10 ml ............................................................ 16.00 (37.50) Inj 6 mg per ml, 10 ml ............................................................ 32.00 (75.00) Inj 9 mg per ml, 10 ml ............................................................ 48.00 (112.50) 1 Pamisol 1 Pamisol 1 Pamisol ✔ Neocate Advance

115

204

AMINO ACID FORMULA – Special Authority see SA1219 – Hospital pharmacy [HP3] Powder (tropical)..................................................................... 53.00 400 g OP

Effective 1 June 2013

47 102 131 BEZAFIBRATE ❋ Tab 200 mg .............................................................................. 9.70 DICLOFENAC SODIUM ❋ Tab EC 25 mg ........................................................................... 1.63 ❋ Tab EC 50 mg .......................................................................... 1.60 (2.13) DOMPERIDONE ❋ Tab 10 mg – For domperidone oral liquid formulation refer, page 179 ............................................................................... 3.25 (11.99) PROMETHAZINE HYDROCHLORIDE ❋‡ Oral liq 5 mg per 5 ml ............................................................. 2.79 (3.10) PHARMACY SERVICES ❋ Brand switch fee........................................................................ 4.33 90 50 50 ✔ Fibalip ✔ Diclofenac Sandoz Diclofenac Sandoz

100 Motilium 100 ml Promethazine Winthrop Elixir 1 fee ✔ BSF Zetlam ✔ BSF Alphapharm ✔ BSF Entapone ✔ BSF Accarb

166

177

Effective 1 July 2013

28 PANTOPRAZOLE ❋ Inj 40 mg ................................................................................. 6.50 1 ✔ Pantocid IV

Patients pay a manufacturer’s surcharge when the Manufacturer’s Price is greater than the Subsidy

44

S29 Unapproved medicine supplied under Section 29 ‡ safety cap reimbursed Sole Subsidised Supply


Check your Schedule for full details Schedule page ref

Subsidy (Mnfr’s price) $

Per

Brand or Generic Mnfr ✔ fully subsidised

Items to be Delisted – effective 1 July 2013 (continued)

54 61 PROPRANOLOL Tab 10 mg ................................................................................ 3.55 CALAMINE a) Only on a prescription b) Not in combination Crm, aqueous, BP ..................................................................... 1.77 100 ✔ Cardinol

100 g

✔ Home Essential

63

METHYLPREDNISOLONE SODIUM SUCCINATE – Retail pharmacy-Specialist Inj 500 mg ............................................................................. 18.00 1 ✔ Solu-Medrol Note – this discontinuation applies only to Pharmacode 265349. The preservative free presentation remains listed. LEVODOPA WITH CARBIDOPA ❋ Tab 100 mg with carbidopa 25 mg – For levodopa with carbidopa oral liquid formulation refer, page 180 ................. 20.00 100 ❋ Tab long-acting 200 mg with carbidopa 50 mg ....................... 47.50 100 ❋ Tab 250 mg with carbidopa 25 mg ......................................... 40.00 100 Note – new presentations of Sinemet and Sinemet CR were listed 1 January 2013. PHARMACY SERVICES ❋ Brand switch fee........................................................................ 4.33 1 fee

119

177

✔ Sinemet ✔ Sinemet CR ✔ Sinemet

✔ BSF CareSens N ✔ BSF CareSens II ✔ BSF CareSens N POP

127

GABAPENTIN Cap 100 mg .............................................................................. 7.16 100 ✔ Nupentin Cap 300 mg ............................................................................ 11.50 100 ✔ Nupentin Note – the Nupentin capsules in the blister pack are to be delisted. The Nupentin capsules in bottles will remain listed as fully funded. AMINO ACID FORMULA – Special Authority see SA1219 – Hospital pharmacy [HP3] Powder .................................................................................. 53.00 400 g OP ✔ Neocate

204

Effective 1 August 2013

97 191 ETRAVIRINE – Special Authority see SA1025 – Retail pharmacy Tab 100 mg .......................................................................... 770.00 120 ✔ Intelence

ENTERAL/ORAL FEED 1KCAL/ML – Special Authority see SA1098 – Hospital pharmacy [HP3] Powder ................................................................................... 78.97 400 g OP ✔ Generaid Plus

Effective 1 September 2013

31 32 INSULIN PEN NEEDLES – Maximum of 100 dev per prescription ❋ 29 g × 12.7 mm ..................................................................... 10.50 100 ✔ ABM

INSULIN SYRINGES, DISPOSABLE WITH ATTACHED NEEDLE – Maximum of 100 dev per prescription ❋ Syringe 0.3 ml with 29 g × 12.7 mm needle ........................... 13.00 100 ✔ ABM ❋ Syringe 0.5 ml with 29 g × 12.7 mm needle ........................... 13.00 100 ✔ ABM ❋ Syringe 0.5 ml with 31 g × 8 mm needle ................................ 13.00 100 ✔ ABM

Three months supply may be dispensed at one time if endorsed “certified exemption” by the prescriber.

❋ Three months or six months, as applicable, dispensed all-at-once

45


Section H page ref

Price (ex man. excl. GST) $ Per

Brand or Generic Manufacturer

Section H changes to Part II

Effective 1 March 2013

18 19 20 BACLOFEN ( price) Tab 10 mg ............................................................................... 5.10 BETAMETHASONE VALERATE ( price) Scalp app 0.1% ........................................................................ 7.75 100 100 ml Pacifen Beta Scalp

BLOOD GLUCOSE KETONE DIAGNOSTIC TEST METER (change of chemical name and  price) 1 meter with 50 lancets, a lancing device, and 10 diagnostic test strips ............................................... 40.00 1 Freestyle Optium BLOOD GLUCOSE DIAGNOSTIC TEST STRIP ( price) Blood glucose test strips ........................................................ 28.75 CLOBETASOL PROPIONATE ( price) Crm 0.05% ................................................................................ 3.68 Oint 0.05% ................................................................................ 3.68 Scalp app 0.05% ....................................................................... 6.96 DANTHRON WITH POLOXAMER ( price) Oral liq 25 mg with poloxamer 200 mg per 5 ml ....................... 21.30 Oral liq 75 mg with poloxamer 1 g per 5 ml .............................. 43.60 INSULIN PEN NEEDLES (delisting) 29 g × 12.7 mm ..................................................................... 10.50 Note – ABM 29 g × 12.7 mm to be delisted 1 May 2013 50 test Freestyle Optium Accu-Chek Performa Dermol Dermol Dermol Pinorax Pinorax Forte ABM

20

25

30 g 30 g 30 ml 300 ml 300 ml 100

27

39

40

INSULIN SYRINGES, DISPOSABLE WITH ATTACHED NEEDLE (delisting) Syringe 0.3 ml with 29 g × 12.7 mm needle ........................... 13.00 100 ABM Syringe 0.5 ml with 29 g × 12.7 mm needle ........................... 13.00 100 ABM Syringe 0.5 ml with 31 g × 8 mm needle ................................ 13.00 100 ABM Note – ABM syringe 0.3 ml with 29 g × 12.7 mm needle, 0.5 ml with 29 g × 12.7 mm needle and 0.5 ml with 31 g × 8 mm needle to be delisted 1 May 2013 KETONE BLOOD BETA-KETONE ELECTRODES ( price) Test strips ............................................................................... 15.50 OXYCODONE HYDROCHLORIDE Inj 50 mg per ml, 1 ml – 1% DV May-13 to 2015 .................... 60.00 PRAMIPEXOLE HYDROCHLORIDE Tab 1 mg ................................................................................. 7.20 SILDENAFIL Tab 25 mg – 1% DV May-13 to 2014 ........................................ 1.85 Tab 50 mg – 1% DV May-13 to 2014 ........................................ 1.85 10 strip Freestyle Optium Ketone OxyNorm Dr Reddy’s Pramipexole Silagra Silagra

41

52 55

5 30

60

4 4

Products with Hospital Supply Status (HSS) are in bold. Expiry date of HSS period is 30 June of the year indicated unless otherwise stated

46


Section H page ref

Price (ex man. excl. GST) $ Per

Brand or Generic Manufacturer

Section H changes to Part II - effective 1 March 2013 (continued)

63 65 TAMOXIFEN CITRATE ( price) Tab 10 mg .............................................................................. 17.50 TRIMETHOPRIM ( price) Tab 300 mg .............................................................................. 9.28 100 50 Genox TMP

Effective 1 February 2013

18 18 19 ATENOLOL Oral liq 25 mg per 5 ml ............................................................ 21.25 AZATHIOPRINE Tab 50 mg .................................................................................. 18.45 BEZAFIBRATE ( price) Tab 200 mg .............................................................................. 9.70 Note – Fibalip tab 200 mg to be delisted 1 March 2013 CAPSAICIN Crm 0.025% .............................................................................. 9.95 ERYTHROMYCIN LACTOBIONATE Inj 300 mg ............................................................................. 70.97 Inj 1 g ( price) ....................................................................... 16.00 Note – Mayne inj 300 mg delisted 1 February 2013 ENTERAL/ORAL FEED 1 KCAL/ML Powder (unflavoured) .............................................................. 78.97 ETRAVIRINE (delisting) Tab 100 mg .......................................................................... 770.00 Note – Intelence tab 100 mg to be delisted 1 August 2013 FLUCLOXACILLIN SODIUM Grans for oral liq 125 mg per 5 ml – 1% DV Sep-12 to 2015 ..... 2.49 Grans for oral liq 250 mg per 5 ml – 1% DV Sep-12 to 2015 ..... 3.25 Note – this listing is a sugar-free formulation with new pharmacodes FLUTICASONE PROPIONATE Metered aqueous nasal spray, 50 µg per dose – 1% DV Apr-13 to 2015 ....................................................... 2.30 GLYCERIN WITH SODIUM SACCHARIN ( price) Suspension ............................................................................. 35.50 GLYCERIN WITH SUCROSE ( price) Suspension ............................................................................. 35.50 300 ml 100 90 Atenolol AFT Imuran Fibalip

22 31

45 g 5 1

Zostrix Mayne Erythrocin IV

31 32

400 g 120

Heparon Junior Intelence

33

100 ml 100 ml

AFT AFT

35

120 dose

Flixonase Hayfever & Allergy Ora-Sweet SF Ora-Sweet

36 36

473 ml 473 ml

Products with Hospital Supply Status (HSS) are in bold. Expiry date of HSS period is 30 June of the year indicated unless otherwise stated

47


Section H page ref

Price (ex man. excl. GST) $ Per

Brand or Generic Manufacturer

Section H changes to Part II - effective 1 February 2013 (continued)

37 HIGH FAT LOW CARBOHYDRATE FORMULA WITH VITAMINS, MINERALS AND TRACE ELEMENTS AND LOW IN PROTEIN AND CARBOHYDRATE (amended chemical name) Powder (vanilla) ...................................................................... 35.50 300 g KetoCal METHYLCELLULOSE ( price) Suspension ............................................................................. 35.50 473 ml Ora-Plus Ora-Blend SF Ora-Blend Apo-Moclobemide Apo-Moclobemide Apo-Nadolol Apo-Nadolol

46 46 46 48

METHYLCELLULOSE WITH GLYCERIN AND SODIUM SACCHARIN ( price) Suspension ............................................................................. 35.50 473 ml METHYLCELLULOSE WITH GLYCERIN AND SUCROSE ( price) Suspension ............................................................................ 35.50 MOCLOBEMIDE (addition of HSS) Tab 150 mg – 1% DV Apr-13 to 2015 ( price) ....................... 81.83 Tab 300 mg – 1% DV Apr-13 to 2015 ( price) ....................... 29.51 NADOLOL ( price and addition of HSS) Tab 40 mg – 1% DV Apr-13 to 2015 ....................................... 15.57 Tab 80 mg – 1% DV Apr-13 to 2015 ....................................... 23.74 473 ml 500 100 100 100

49

51

ONDANSETRON (delisting) Inj 2 mg per ml, 2 ml ............................................................... 14.40 5 Zofran Inj 2 mg per ml, 4 ml ............................................................... 23.20 5 Zofran Note – Zofran inj 2 mg per ml, 2 ml and 2 mg per ml, 4 ml will be delisted from 1 April 2013 PARACETAMOL Inj 10 mg per ml, 100 ml – 1% DV Apr-13 to 2014 .................. 22.50 10 Paracetamol–AFT Arrow-Quinapril 5 Arrow-Quinapril 10 Arrow-Quinapril 20

53 57

QUINAPRIL Tab 5 mg – 1% DV Apr-13 to 2015 ........................................... 3.44 90 Tab 10 mg – 1% DV Apr-13 to 2015 ......................................... 4.64 90 Tab 20 mg – 1% DV Apr-13 to 2015 ......................................... 6.34 90 Note – Accupril tab 5 mg, 10 mg and 20 mg will be delisted from 1 April 2013 RECOMBINANT COAGULATION FACTOR VIIA Combination pack (powder and diluent for inj) 8 mg............ 9,310.00 VENLAFAXINE Tab 225 mg ............................................................................ 35.12 1 28

57 66

NovoSeven RT Arrow-Venlafaxine XR

Effective 1 January 2013

15 ACICLOVIR Inj 250 mg – 1% DV Mar-13 to 2015 ...................................... 14.09 Note – Pfizer inj 250 mg to be delisted 1 March 2013 BEZAFIBRATE Tab 200 mg – 1% DV Mar-13 to 2015 ...................................... 9.70 Note – Fibalip tab 200 mg to be delisted 1 March 2013 Products with Hospital Supply Status (HSS) are in bold. Expiry date of HSS period is 30 June of the year indicated unless otherwise stated 5 Zovirax IV

19

90

Bezalip

48


Section H page ref

Price (ex man. excl. GST) $ Per

Brand or Generic Manufacturer

Section H changes to Part II - effective 1 January 2013 (continued)

21 CALAMINE (change of HSS brand) Crm aqueous, BP – 1% DV Mar-13 to 2015 .............................. 1.77 Note – Home Essential crm aqueous, BP to be delisted from 1 March 2013 CALCITRIOL Cap 0.25 µg ............................................................................ 10.10 Cap 0.5 µg .............................................................................. 18.73 CALCIUM GLUCONATE (pack size change) Gel, 2.5%, 50 g ..................................................................... 420.00 21.00 CETOMACROGOL (pack size change) Crm BP 100 g ......................................................................... 33.00 1.65 CHLORHEXIDINE (pack size change) Foaming liquid 4%, 50ml ........................................................ 37.20 1.86 Soln 5%, 500 ml.................................................................... 186.00 15.50 CHLORHEXIDINE GLUCONATE (pack size change) Obstetric lotion 1%, 200 ml...................................................... 81.00 6.75 CHLORHEXIDINE IN ALCOHOL (pack size change) Soln 0.5% with 70% alcohol, 25 ml (tinted pink) .................... 232.50 1.55 Soln 0.5% with 70% alcohol, 100 ml (tinted pink)..................... 31.80 2.65 Soln 0.5% with 70% alcohol, 100 ml (tinted red) ...................... 34.80 2.90 Soln 0.5% with 70% alcohol, 500 ml (tinted pink)..................... 65.40 5.45 Soln 0.5% with 70% alcohol, 500 ml (tinted red) ...................... 70.80 5.90 Soln 2% with 70% alcohol, 100 ml (tinted pink) ....................... 42.48 3.54 Soln 2% with 70% alcohol, 100 ml (tinted red) ......................... 46.32 3.86 Soln 2% with 70% alcohol, 500 ml (tinted red) ...................... 114.72 9.56 CYCLOSPORIN ( price) Cap 25 mg ............................................................................. 44.63 Cap 50 mg .............................................................................. 88.91 Cap 100 mg .......................................................................... 177.81 DEXAMPHETAMINE SULPHATE (addition of HSS) Tab 5 mg – 1% DV Mar-13 to 2015 ........................................ 16.50 100 g Pharmacy Health

21

100 100 20 1 20 1 20 1 12 1 12 1 150 1 12 1 12 1 12 1 12 1 12 1 12 1 12 1 50 50 50 100

Calcitriol-AFT Calcitriol-AFT healthE healthE healthE healthE healthE healthE healthE healthE healthE healthE healthE healthE healthE healthE healthE healthE healthE healthE healthE healthE healthE healthE healthE healthE healthE healthE Neoral Neoral Neoral PSM

22

23 24

24

24

26

28

Products with Hospital Supply Status (HSS) are in bold. Expiry date of HSS period is 30 June of the year indicated unless otherwise stated

49


Section H page ref

Price (ex man. excl. GST) $ Per

Brand or Generic Manufacturer

Section H changes to Part II - effective 1 January 2013 (continued)

28 DICLOFENAC SODIUM Tab EC 25 mg – 1% DV Mar-13 to 2015 ................................... 4.00 Tab EC 50 mg – 1% DV Mar-13 to 2015 ................................. 16.00 DOMPERIDONE Tab 10 mg – 1% DV Mar-13 to 2015 ........................................ 3.25 100 500 100 Apo-Diclo Apo-Diclo Prokinex

29 30

DOXORUBICIN Inj 50 mg – 1% DV Mar-13 to 2015 ........................................ 17.00 1 Arrow-Doxorubicin Inj 200 mg – 1% DV Mar-13 to 2015 ...................................... 65.00 1 Arrow-Doxorubicin Note – Doxorubicin Ebewe and DBL Doxorubicin inj 50 mg and 100 mg to be delisted 1 March 2013 ETHINYLOESTRADIOL WITH LEVONORGESTREL Tab 50 µg with levonorgestrel 125 µg and 7 inert tab................. 9.45 HYDROCORTISONE BUTYRATE (addition of HSS) Lipocream 0.1% – 1% DV Mar-13 to 2015 ................................ 2.30 6.85 Oint 0.1% – 1% DV Mar-13 to 2015 .......................................... 6.85 Milky emul 0.1% – 1% DV Mar-13 to 2015 ............................... 6.85 Scalp lotn 0.1% – 1% DV Mar-13 to 2015 ................................. 3.65 84 30 g 100 g 100 g 100 ml 100 ml Microgynon 50 ED Locoid Lipocream Locoid Lipocream Locoid Locoid Crelo Locoid

32 38

38

HYDROXYETHYL STARCH 130/0.4 WITH MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ACETATE AND SODIUM CHLORIDE Inj 6% with magnesium chloride 0.03%, potassium chloride 0.03%, sodium acetate 0.463% and sodium chloride 0.6%, 500ml ...................................... 198.00 20 Volulyte 6% HYDROXYETHYL STARCH 130/0.4 WITH SODIUM CHLORIDE (chemical name and presentation amended) Inj 6% with sodium chloride 0.9 %, 500 ml .......................... 198.00 20 Voluven IODINE WITH ALCOHOL (pack size change) Soln 1% with 70% alcohol, 100 ml......................................... 111.60 9.30 ISOPROPYL ALCOHOL (pack size change) Soln 70%, 500 ml.................................................................... 67.80 5.65 ISONIAZID (addition of HSS) Tab 100 mg – 1% DV Mar-13 to 2015 .................................... 20.00 12 1 12 1 100 healthE healthE healthE healthE PSM Sinemet Sinemet Sinemet CR

38 40

41

41 43

LEVODOPA WITH CARBIDOPA (new formulation) Tab 100 mg with carbidopa 25 mg .......................................... 20.00 100 Tab 250 mg with carbidopa 25 mg ......................................... 40.00 100 Tab long-acting 200 mg with carbidopa 50 mg ........................ 47.50 100 Note – Sinemet and Sinemet CR (previous presentations) to be delisted 1 July 2013. LEVONORGESTREL Tab 750 µg ............................................................................ 12.50 2

43

Next Choice

Products with Hospital Supply Status (HSS) are in bold. Expiry date of HSS period is 30 June of the year indicated unless otherwise stated

50


Section H page ref

Price (ex man. excl. GST) $ Per

Brand or Generic Manufacturer

Section H changes to Part II - effective 1 January 2013 (continued)

43 47 LISURIDE HYDROGEN MALEATE ( price) Tab 200 µg ............................................................................ 25.00 30 Dopergin

METHYLPREDNISOLONE SODIUM SUCCINATE Inj 500 mg – 1% DV Oct-12 to 2015 ....................................... 18.00 1 Solu-Medrol Note – Solu-Medrol inj 500 mg to be delisted 1 March 2013. Note the preservative free presentation remains available and on HSS. OIL IN WATER EMULSION (pack size change) Crm 100 g .............................................................................. 32.00 1.60 PANTOPRAZOLE Inj 40 mg – 1% DV Sep-11 to 2014 .......................................... 6.50 Note – Pantocid IV delisted 1 January 2013 PETHIDINE HYDROCHLORIDE ( price and addition of HSS) Tab 50 mg – 1% DV Mar-13 to 2015 ........................................ 3.95 Tab 100 mg – 1% DV Mar-13 to 2015 ...................................... 5.80 PHENOBARBITONE ( price and addition of HSS) Tab 15 mg – 1% DV Mar-13 to 2015 ...................................... 28.00 Tab 30 mg – 1% DV Mar-13 to 2015 ...................................... 29.00 PIZOTIFEN ( price and addition of HSS) Tab 500 µg – 1% DV Mar-13 to 2015 ..................................... 23.21 POSACONAZOLE Oral liq 40 mg per ml ............................................................. 761.13 PREDNISOLONE SODIUM PHOSPHATE ( price) Oral liq 5 mg per ml ................................................................. 10.45 RETINOL PALMITATE (pack size change) Oint 50 g ................................................................................ 57.20 2.86 SOFT WHITE PARAFFIN WITH PARAFFIN LIQUID (pack size change) Oint 50% with 50% paraffin liquid, 100 g .................................. 62.00 3.10 SORBOLENE WITH GLYCERIN (pack size change) Crm with 10% glycerine, 100 g ................................................ 64.00 3.20 Crm with 10% glycerine, 500 ml .............................................. 87.60 7.30 TESTOSTERONE UNDECANOATE Inj 250 mg per ml, 4 ml ........................................................... 86.00 20 1 1 healthE healthE Pantocid IV

50

53

54

10 10 500 500 100 105 ml 30 ml 20 1 20 1 20 1 12 1 1

PSM PSM PSM PSM Sandomigran Noxafil Redipred healthE healthE healthE healthE healthE healthE healthE healthE Reandron 1000

54

54 55 55 58

62

62

64

Products with Hospital Supply Status (HSS) are in bold. Expiry date of HSS period is 30 June of the year indicated unless otherwise stated

51


Section H page ref

Price (ex man. excl. GST) $ Per

Brand or Generic Manufacturer

Section H changes to Part II - effective 1 January 2013 (continued)

65 TRAMADOL HYDROCHLORIDE ( price, brand name change) Tab sustained-release 100 mg ................................................... 2.14 Tab sustained-release 150 mg ................................................... 3.21 Tab sustained-release 200 mg ................................................... 4.28 20 20 20 Tramal SR 100 Retard Tramal SR 150 Retard Tramal SR 200 Retard

Effective 1 December 2012

19 AZITHROMYCIN Tab 250 mg ............................................................................ 10.00 Tab 500 mg – 1% DV Feb-13 to 2015 ....................................... 1.25 Note – Arrow-Azithromycin 500 mg tab to be delisted 1 February 2013 CALCIUM CARBONATE Oral liq 1,250 mg per 5 ml (500 mg elemental per 5 ml) ................................................ 39.00 CLONIDINE HYDROCHLORIDE ( price and addition of HSS) Tab 150 µg – 1% DV Feb-13 to 2015 ..................................... 34.32 30 2 Apo-Azithromycin Apo-Azithromycin

22

500 ml 100

Roxane Catapres

26 30

DILTIAZEM HYDROCHLORIDE Cap long-acting 120 mg – 5% DV Feb-13 to 2015 .................. 31.83 500 Apo-Diltiazem CD Cap long-acting 180 mg – 5% DV Feb-13 to 2015 .................. 47.67 500 Apo-Diltiazem CD Cap long-acting 240 mg – 5% DV Feb-13 to 2015 .................. 63.58 500 Apo-Diltiazem CD Note – Cardizem CD cap long-acting 120 mg, 180 mg and 240 mg to be delisted 1 February 2013 EFAVIRENZ WITH EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE Tab 600 mg with emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg........................ 1,313.19 30 EMTRICITABINE WITH TENOFOVIR DISOPROXIL FUMARATE Tab 200 mg with tenofovir disoproxil fumarate 300 mg .......... 838.20 ETANERCEPT Inj 50 mg prefilled syringe .................................................. 1,899.92 ETRAVIRINE Tab 200 mg ......................................................................... 770.00 FLUOROURACIL SODIUM ( price and addition of HSS) Crm 5% – 1% DV Feb-13 to 2015 ........................................... 25.16 FUROSEMIDE (addition of HSS) Tab 500 mg – 1% DV Feb-13 to 2015 ..................................... 25.00 HEPARIN WITH SODIUM CHLORIDE (delisted) Inf 25,000 iu with 0.9% sodium chloride .................................... 7.25 7.67 IMIPENEM WITH CILASTATIN Inj 500 mg with cilastatin 500 mg – 1% DV Dec-12 to 2014 .... 18.37 30 4 60 20 g 50 250 ml 500 ml 1

31

Atripla Truvada Enbrel Intelence Efudix Urex Forte Baxter Baxter Primaxin

31 32 33 35 36 37

39

Products with Hospital Supply Status (HSS) are in bold. Expiry date of HSS period is 30 June of the year indicated unless otherwise stated

52


Section H page ref

Price (ex man. excl. GST) $ Per

Brand or Generic Manufacturer

Section H changes to Part II - effective 1 December 2012 (continued)

40 45 45 INSULIN ASPART WITH INSULIN ASPART PROTAMINE (change to chemical name) Inj 100 iu per ml, 3 ml prefilled pen ......................................... 52.15 5 MAGNESIUM SULPHATE Inj 2 mmol per ml, 5 ml – 1% DV Feb-13 to 2015.................... 18.35 MAGNESIUM SULPHATE (change to line description) Inj 49.3% 2 mmol per ml, 5 ml ............................................... 26.60 Note – Mayne inj to be delisted 1 February 2013 METFORMIN HYDROCHLORIDE (brand name change) Tab immediate-release 500 mg – 1% DV Oct-12 to 2015 ........ 12.30 Tab immediate-release 850 mg – 1% DV Oct-12 to 2015 ........ 10.10 48 49 52 54 METOPROLOL TARTRATE Inj 1 mg per ml, 5 ml – 1% DV Dec-12 to 2015 ....................... 24.00 MICONAZOLE Oral gel 20 mg per g – 1% DV Feb-13 to 2015 .......................... 4.95 ONDANSETRON Inj 2 mg per ml, 4 ml ................................................................. 2.98 10 10 NovoMix 30 FlexPen Martindale Mayne

45

1,000 500

Apo-Metformin Apotex Apo-Metformin Apotex Lopresor Decozol Ondanaccord

5 40 g 5

PAMIDRONATE DISODIUM Inj 3 mg per ml, 10 ml – 1% DV Feb-13 to 2014 ..................... 16.00 1 Pamidronate BNM Inj 6 mg per ml, 10 ml – 1% DV Feb-13 to 2014 ..................... 32.00 1 Pamidronate BNM Inj 9 mg per ml, 10 ml – 1% DV Feb-13 to 2014 ..................... 48.00 1 Pamidronate BNM Note – Pamisol inj 3 mg per ml, 6 mg per ml and 9 mg per ml, 10 ml to be delisted 1 February 2013. PARAFFIN White soft – 1% DV Feb-13 to 2015 .......................................... 0.92 10 g healthE Note – Paraffin yellow soft (PSM) to be delisted 1 February 2013. Note – DV Limit applies to pack sizes of 30 g or less, and to white soft paraffin and yellow soft paraffin. PROMETHAZINE HYDROCHLORIDE Oral liq 5 mg per 5 ml – 1% DV Feb-13 to 2015 ........................ 2.79 Note – Promethazine Winthrop Elixir to be delisted 1 February 2013 100 ml Allersoothe

55

58

58

RECOMBINANT FACTOR VIII Inj 250 IU .............................................................................. 225.00 1 Inj 500 IU .............................................................................. 450.00 1 Inj 1,000 IU ........................................................................... 900.00 1 Inj 2,000 IU ........................................................................ 1,800.00 1 Inj 3,000 IU ........................................................................ 2,700.00 1 Note – This listing is for dual chamber syringe presentation with new Pharmacodes. SILDENAFIL Tab 100 mg – 1% DV May-13 to 2014 ...................................... 7.45 4

Xyntha Xyntha Xyntha Xyntha Xyntha

62

Silagra

Products with Hospital Supply Status (HSS) are in bold. Expiry date of HSS period is 30 June of the year indicated unless otherwise stated

53


Section H page ref

Price (ex man. excl. GST) $ Per

Brand or Generic Manufacturer

Section H changes to Part II - effective 1 December 2012 (continued)

65 TEMOZOLOMIDE Cap 5 mg – 1% DV Mar-12 to 2014 2013 ............................... 16.00 Cap 20 mg – 1% DV Mar-12 to 2014 2013 ............................. 72.00 Cap 100 mg – 1% DV Mar-12 to 2014 2013 ......................... 350.00 Cap 250 mg – 1% DV Mar-12 to 2014 2013 ......................... 820.00 5 5 5 5 Temaccord Temaccord Temaccord Temaccord

Section H changes to Part III

Effective 1 January 2013

ALBENDAZOLE Tab 200 mg ....................................................................... Albenza Zentel Indefinite supply to cover treatment of hydatid disease, strongyloidiasis, toxocariasis, ancylostomiasis, neurocysticerosis and schistosomiasis (where first line treatment has failed) until EC NPPA funding is approved (Section 29) DEXTROSE Inj 5%, 10 ml Where required for antibiotic treatment funded under DCS or HEC NPPA NETILMICIN Inj 150 mg per 1.5 ml Up to 2 weeks supply for any appropriate indication (extension for up to 6 weeks supply for endocarditis should be applied for under Hospital EC NPPA) SODIUM CHLORIDE Tab 600 mg Slow Sodium Indefinite supply for salt wasting nephropathy (Section 29) Inj 0.9% Where required for injection of antibiotic treatment funded under DCS or HEC NPPA WATER Purified for inj Where required for injection of antibiotic treatment funded under DCS or HEC NPPA

Products with Hospital Supply Status (HSS) are in bold. Expiry date of HSS period is 30 June of the year indicated unless otherwise stated

54


Index

Pharmaceuticals and brands Symbols 50X 3.0 Reservoir .............................................. 22 A Acarbose ..................................................... 27, 39 Accarb ............................................................... 27 Accu-Chek Performa .............................. 27, 32, 46 Aciclovir ............................................................ 48 AFT-Leflunomide ................................................ 40 Albendazole ....................................................... 54 Allersoothe......................................................... 53 Alphapharm ....................................................... 28 Amino acid formula ...................................... 44, 45 Amirol .......................................................... 35, 43 Amitriptyline ................................................. 35, 43 Amoxycillin clavulanate ...................................... 40 Animas Vibe................................................. 29, 30 Apo-Azithromycin .............................................. 52 Apo-Diclo..................................................... 25, 50 Apo-Diltiazem CD ............................................... 52 Apo-Moclobemide........................................ 34, 48 Apo-Nadolol ................................................. 33, 48 Arrow-Azithromycin ..................................... 34, 44 Arrow-Brimonidine ............................................. 31 Arrow-Doxorubicin ....................................... 26, 50 Arrow-Enalapril .................................................. 39 Arrow-Lisinopril ................................................. 43 Arrow-Quinapril 5 ......................................... 20, 48 Arrow-Quinapril 10 ....................................... 20, 48 Arrow-Quinapril 20 ....................................... 20, 48 Arrow-Testosterone ........................................... 41 Arrow-Venlafaxine XR................................... 21, 48 Atenolol ....................................................... 20, 47 Atenolol AFT ................................................ 20, 47 Atorvastatin........................................................ 41 Atripla ................................................................ 52 Auranofin ........................................................... 40 Ava 30 ED.......................................................... 28 Avonex Pen ........................................................ 25 Azathioprine ................................................. 21, 47 Azithromycin .......................................... 34, 44, 52 B Baclofen ...................................................... 33, 46 Batrafen ............................................................. 39 Beta Cream ........................................................ 32 Betamethasone valerate ............................... 32, 46 Beta Ointment .................................................... 32 Beta Scalp ................................................... 32, 46 Bezafibrate ................................. 24, 33, 44, 47, 48 Bezalip ......................................................... 24, 48 Bicillin LA........................................................... 25 Blood glucose diagnostic test strip ... 27, 32, 39, 46 Blood ketone diagnostic test meter ............... 32, 46 Boostrix ............................................................. 38 Brimonidine tartrate ............................................ 31 BSF Accarb .................................................. 20, 44 BSF Alphapharm .......................................... 20, 44 BSF Arrow-Brimonidine ...................................... 42 BSF Ava 30 ED................................................... 40 BSF Candestar ................................................... 40 BSF CareSens II ........................................... 28, 45 BSF CareSens N ........................................... 28, 45 BSF CareSens N POP ................................... 28, 45 BSF Entapone .............................................. 20, 44 BSF Plendil ER ............................................. 26, 43 BSF Zetlam .................................................. 20, 44 C Calamine.......................................... 24, 40, 45, 49 Calcitriol ...................................................... 24, 49 Calcitriol-AFT ............................................... 24, 49 Calcium carbonate ............................................. 52 Calcium gluconate ............................................. 49 Candesartan....................................................... 29 Candestar .......................................................... 29 Capsaicin ..................................................... 21, 47 Carboplatin ........................................................ 35 Cardinol ............................................................. 45 Cardizem CD ................................................ 33, 43 Catapres ............................................................ 52 Cetomacrogol .................................................... 49 Chlorhexidine ..................................................... 49 Chlorhexidine gluconate ............................... 39, 49 Chlorhexidine in alcohol...................................... 49 Ciclopirox olamine.............................................. 39 Cilazapril ............................................................ 39 Cisplatin....................................................... 35, 37 Clobetasol propionate................................... 32, 46 Clonidine hydrochloride ...................................... 52 Combivir ............................................................ 39 Comfort ............................................................. 31 Comfort Short .................................................... 31 Contact-D .......................................................... 30 Comtan .............................................................. 40 Curam ............................................................... 40 Cyclosporin.................................................. 35, 49 D Dabigatran ......................................................... 41 Daktarin ....................................................... 33, 43 Danthron with poloxamer.............................. 32, 46 DBL Cisplatin ............................................... 35, 37 Deca-Durabolin Orgaject .................................... 41 Decozol ............................................................. 53 Dermol......................................................... 32, 46 Dexamphetamine sulphate.................................. 49 Dextrochlorpheniramine maleate ......................... 34

55


Index

Pharmaceuticals and brands Dextrose ............................................................ 54 Diclofenac Sandoz ....................................... 32, 44 Diclofenac sodium ........................... 25, 32, 44, 50 Diltiazem hydrochloride .......................... 33, 43, 52 Diphtheria, tetanus and pertussis vaccine ........... 38 Docetaxel ........................................................... 42 Domperidone ................................... 25, 33, 44, 50 Dopergin ...................................................... 35, 51 Doxorubicin ........................................... 26, 33, 50 Dr Reddy’s Atorvastatin...................................... 41 Dr Reddy’s Pramipexole ............................... 20, 46 E Efavirenz with emtricitabine and tenofovir disoproxil fumarate.......................................... 52 Emtricitabine with tenofovir disoproxil fumarate .. 52 Efudix ................................................................ 52 Enalapril ............................................................. 39 Enbrel ................................................................ 52 Entacapone .................................................. 28, 40 Entapone ........................................................... 28 Enteral/oral feed 1 kcal/ml ...................... 21, 45, 47 Erythrocin IV ................................................ 33, 47 Erythromycin lactobionate ............................ 33, 47 Etanercept.......................................................... 52 Ethambutol hydrochloride ................................... 28 Ethinyloestradiol with levonorgestrel ............. 28, 50 Etravirine................................................ 45, 47, 52 F Famotidine ......................................................... 43 Famox................................................................ 43 Felo 5 ER ........................................................... 41 Felo 10 ER ......................................................... 41 Felodipine .................................................... 31, 41 Fibalip .................................................... 33, 44, 47 Flixonase Hayfever & Allergy .................. 21, 40, 47 Flucloxacillin sodium .............................. 21, 41, 47 Fluorometholone ................................................ 40 Fluorouracil sodium............................................ 52 Flutamide ........................................................... 20 Flutamin S29...................................................... 20 Fluticasone propionate ........................... 21, 40, 47 FML ................................................................... 40 FreeStyle Lite ..................................................... 39 Freestyle Optium .................................... 27, 32, 46 Freestyle Optium Ketone ............................... 32, 46 Furosemide ........................................................ 52 G Gabapentin ........................................................ 45 Generaid Plus..................................................... 45 Genox .......................................................... 33, 47 Gentamicin sulphate ........................................... 20 Glucobay ........................................................... 39 Glycerin with sodium saccharin .................... 34, 47 Glycerin with sucrose ................................... 34, 47 H Heparin with sodium chloride ............................. 52 Heparon Junior ............................................ 21, 47 High fat low carbohydrate formula ................ 29, 48 Home Essential .................................................. 45 Hydrocortisone butyrate ..................................... 50 Hydroxyethyl starch 130/0.4 with magnesium chloride, potassium chloride, sodium acetate and sodium chloride........................................ 50 Hydroxyethyl starch 130/0.4 with sodium chloride .............................................. 50 I Imuran ......................................................... 21, 47 Inset 30 ............................................................. 31 Inset II................................................................ 30 Insulin aspart with insulin aspart protamine......... 53 Insulin pen needles....................................... 45, 46 Insulin pump ................................................ 21, 29 Insulin pump infusion set (steel cannula) ...... 23, 30 Insulin pump infusion set (teflon cannula, angle insertion) ......................................... 22, 31 Insulin pump infusion set (teflon cannula, angle insertion with insertion device) ............... 31 Insulin pump infusion set (teflon cannula, straight insertion) ............................................ 22 Insulin pump infusion set (teflon cannula, straight insertion with insertion device) ...... 24, 30 Insulin pump reservoir ........................................ 22 Insulin syringes, disposable with attached needle ........................................ 45, 46 Intelence ................................................ 45, 47, 52 Iodine with alcohol ............................................. 50 Imipenem with cilastatin ..................................... 52 Interferon beta-1-alpha ....................................... 25 Isoniazid ............................................................ 50 Isopropyl alcohol................................................ 50 K KetoCal ........................................................ 29, 48 Ketone blood beta-ketone electrodes ............ 32, 46 L Lamivudine .................................................. 28, 39 Lansoprazole ............................................... 35, 43 Lanzol Relief ................................................ 35, 43 Leflunomide ....................................................... 40 Letara ................................................................ 42 Letrozole ............................................................ 42 Levodopa with carbidopa ....................... 25, 45, 50 Levonorgestrel ............................................. 25, 50 Lipitor ................................................................ 41 Lisinopril ............................................................ 43

56


Index

Pharmaceuticals and brands Lisuride hydrogen maleate............................ 35, 51 Locoid ............................................................... 50 Locoid Crelo ...................................................... 50 Locoid Lipocream .............................................. 50 Lopresor ............................................................ 53 M Macrogol 3350 .................................................. 39 Magnesium sulphate .......................................... 53 Megace........................................................ 35, 43 Megestrol acetate......................................... 35, 43 Metformin hydrochloride .............................. 41, 53 Methylcellulose ............................................ 34, 48 Methylcellulose with glycerin and sodium saccharin .................................................. 34, 48 Methylcellulose with glycerin and sucrose .... 34, 48 Methylprednisolone sodium succinate .... 41, 45, 51 Metoprolol tartrate .............................................. 53 Miconazole ............................................ 33, 43, 53 Microgynon 50 ED ............................................. 50 Moclobemide ............................................... 34, 48 Motilium ...................................................... 33, 44 Movicol.............................................................. 39 Myambutol......................................................... 28 N Nadolol ........................................................ 33, 48 Nandrolone decanoate........................................ 41 Neocate ............................................................. 45 Neocate Advance ............................................... 44 Neoral .......................................................... 35, 49 Netilmicin........................................................... 54 Nevirapine .................................................... 35, 43 Next Choice ................................................. 25, 50 NovoMix 30 FlexPen ........................................... 53 NovoSeven RT ................................................... 48 Noxafil ......................................................... 25, 51 Nupentin ............................................................ 45 O Oil in water emulsion .......................................... 51 On Call Advanced ............................................... 39 Ondanaccord ..................................................... 53 Ondansetron ................................................ 48, 53 Ora-Blend .................................................... 34, 48 Ora-Blend SF................................................ 34, 48 Ora-Plus ...................................................... 34, 48 Ora-Sweet.................................................... 34, 47 Ora-Sweet SF ............................................... 34, 47 Oxycodone hydrochloride ....................... 20, 40, 46 OxyNorm ............................................... 20, 40, 46 P Pacifen ........................................................ 33, 46 Pamidronate BNM .............................................. 53 Pamidronate disodium ........................... 34, 44, 53 Pamisol ....................................................... 34, 44 Pantocid IV .................................................. 44, 51 Pantoprazole ................................................ 44, 51 Paracetamol....................................................... 48 Paracetamol–AFT ............................................... 48 Paradigm 1.8 Reservoir ...................................... 22 Paradigm 3.0 Resevoir ....................................... 22 Paradigm 522 .................................................... 21 Paradigm 722 .................................................... 21 Paradigm Mio MMT-921 .................................... 24 Paradigm Mio MMT-923 .................................... 24 Paradigm Mio MMT-925 .................................... 24 Paradigm Mio MMT-941 .................................... 24 Paradigm Mio MMT-943 .................................... 24 Paradigm Mio MMT-945 .................................... 24 Paradigm Mio MMT-965 .................................... 24 Paradigm Mio MMT-975 .................................... 24 Paradigm Quick-Set MMT-386 ........................... 22 Paradigm Quick-Set MMT-387 ........................... 23 Paradigm Quick-Set MMT-396 ........................... 23 Paradigm Quick-Set MMT-397 ........................... 23 Paradigm Quick-Set MMT-398 ........................... 23 Paradigm Quick-Set MMT-399 ........................... 23 Paradigm Silhouette ........................................... 22 Paradigm Silhouette MMT-368 ........................... 22 Paradigm Silhouette MMT-377 ........................... 22 Paradigm Silhouette MMT-378 ........................... 22 Paradigm Silhouette MMT-381 ........................... 22 Paradigm Silhouette MMT-382 ........................... 22 Paradigm Silhouette MMT-383 ........................... 22 Paradigm Silhouette MMT-384 ........................... 22 Paradigm Sure-T MMT-864 ................................ 23 Paradigm Sure-T MMT-866 ................................ 23 Paradigm Sure-T MMT-874 ................................ 23 Paradigm Sure-T MMT-876 ................................ 23 Paradigm Sure-T MMT-884 ................................ 24 Paradigm Sure-T MMT-886 ................................ 24 Paraffin .............................................................. 53 Penicillin G benzathine [Benzathine benzylpenicillin] ...................... 25, 37 Pethidine hydrochloride ................................ 35, 51 Pharmacy Health ................................................ 49 Pharmacy services... 20, 26, 28, 40, 42, 43, 44, 45 Phenobarbitone ............................................ 35, 51 Phentolamine mesylate ...................................... 41 Pinorax ........................................................ 32, 46 Pinorax Forte ................................................ 32, 46 Pizotifen ....................................................... 35, 51 Plendil ER .......................................................... 31 Polaramine......................................................... 34

57


Pharmaceutical Management Agency Level 9, 40 Mercer Street, PO Box 10-254, Wellington 6143, New Zealand Phone: 64 4 460 4990 - Fax: 64 4 460 4995 - www.pharmac.govt.nz Freephone Information line (9am-5pm weekdays) 0800 66 00 50 ISSN 1172-9376 (Print) ISSN 1179-3686 (Online)

While care has been taken in compiling this Update, Pharmaceutical Management Agency takes no responsibility for any errors or omissions and shall not be liable to any person for any damages or loss arising out of reliance by that person for any purpose on any of the contents of this Update. Errors and omissions brought to the attention of Pharmaceutical Management Agency will be corrected if necessary by an erratum or otherwise in the next edition of the Update.

If Undelivered, Return To: PO Box 10-254, Wellington 6143, New Zealand


Index

Pharmaceuticals and brands Posaconazole .............................................. 25, 51 Pradaxa ............................................................. 41 Pramipexole hydrochloride ........................... 20, 46 Prednisolone sodium phosphate ................... 35, 51 Primaxin ............................................................ 52 Prokinex....................................................... 25, 50 Promethazine Winthrop Elixir ........................ 33, 44 Promethazine hydrochloride ................... 33, 44, 53 Propranolol ........................................................ 45 Protamine sulphate ............................................ 33 Q Quick-Set MMT-390........................................... 23 Quick-Set MMT-391........................................... 23 Quick-Set MMT-392........................................... 23 Quick-Set MMT-393........................................... 23 Quinapril ...................................................... 20, 48 R Reandron 1000 ............................................ 25, 51 Recombinant coagulation factor VIIa................... 48 Recombinant factor VIII ...................................... 53 Redipred ...................................................... 35, 51 Regitine ............................................................. 41 Retinol palmitate ................................................ 51 Ridaura .............................................................. 40 Rivacol .............................................................. 39 Roxane .............................................................. 52 S Sandomigran ............................................... 35, 51 Silagra ............................................. 20, 27, 46, 53 Sildenafil .................................... 20, 27, 43, 46, 53 Silhouette MMT-371........................................... 22 Silhouette MMT-373........................................... 22 Sinemet ................................................. 25, 45, 50 Sinemet CR............................................ 25, 45, 50 Sodium chloride ................................................. 54 Sodium cromoglycate ........................................ 40 Soft white paraffin with paraffin liquid ................. 51 Solu-Medrol ........................................... 41, 45, 51 Sorbolene with glycerin ...................................... 51 Sure-T MMT-863 ............................................... 23 Sure-T MMT-865 ............................................... 23 Sure-T MMT-873 ............................................... 23 Sure-T MMT-875 ............................................... 23 Sure-T MMT-883 ............................................... 23 Sure-T MMT-885 ............................................... 24 T Tamoxifen citrate.......................................... 33, 47 Taxotere............................................................. 42 Temaccord ........................................................ 54 Temozolomide ................................................... 54 Testosterone undecanoate...................... 25, 41, 51 TMP............................................................. 32, 47 Tramadol hydrochloride................................ 25, 52 Tramal SR 100............................................. 25, 52 Tramal SR 150............................................. 25, 52 Tramal SR 200............................................. 25, 52 Trimethoprim ............................................... 32, 47 Truvada ............................................................. 52 U Urex Forte .......................................................... 52 V Venlafaxine .................................................. 21, 48 Viagra .......................................................... 27, 43 Vicrom ............................................................... 40 Viramune ..................................................... 35, 43 Volulyte 6% ........................................................ 50 Voluven.............................................................. 50 W Water ................................................................. 54 X Xyntha ............................................................... 53 Z Zapril ................................................................. 39 Zeffix.................................................................. 39 Zetlam ............................................................... 28 Zidovudine [AZT] with lamivudine ................. 28, 39 Zofran ................................................................ 48 Zostrix.......................................................... 21, 47 Zovirax IV ........................................................... 48

58

Metadata

Title

Schedule Update - effective 1 March 2013

Abstract

Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 March 2013 Cumulative for January, February and March 2013 Section H cumulative for December 2012, January, February and March 2013 Contents Summary of PHARMAC decisions effective 1 March 2013 …..…

Page 1

icon

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.